Difference between revisions of "Team:XMU-China/Human Practices"

Line 2: Line 2:
  
 
<head>
 
<head>
     <meta charset="UTF-8" name="viewport" content="width=device-width, initial-scale=1.0, <sub>max</sub>imum-scale=1.0, user-scalable=0">
+
     <meta charset="UTF-8" name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=0">
 
     <meta http-equiv="X-UA-Compatible" content="IE=edge">
 
     <meta http-equiv="X-UA-Compatible" content="IE=edge">
 
     <!--ie使用edge渲染模式-->
 
     <!--ie使用edge渲染模式-->
     <meta content="width=device-width,initial-scale=1.0,<sub>max</sub>imum-scale=1.0,user-scalable=no" id="viewport" name="viewport">
+
     <meta content="width=device-width,initial-scale=1.0,maximum-scale=1.0,user-scalable=no" id="viewport" name="viewport">
 
     <meta name="renderer" content="webkit">
 
     <meta name="renderer" content="webkit">
 
     <!--360渲染模式-->
 
     <!--360渲染模式-->
Line 12: Line 12:
 
     <meta name="keywords" content="" />
 
     <meta name="keywords" content="" />
 
     <link rel="shortcut icon" href="favicon.ico" type="image/x-icon" />
 
     <link rel="shortcut icon" href="favicon.ico" type="image/x-icon" />
     <meta name="apple-touch-fullscreen" content="yes" />
+
     <meta name="apple-touch-fullscreen" content="yes" /><!-- 是否启用 WebApp 全屏模式,删除苹果默认的工具栏和菜单栏 -->
    <!-- 是否启用 WebApp 全屏模式,删除苹果默认的工具栏和菜单栏 -->
+
     <meta name="apple-mobile-web-app-status-bar-style" content="black" /><!-- 设置苹果工具栏颜色:默认值为 default,可以定为 black和 black-translucent-->
     <meta name="apple-mobile-web-app-status-bar-style" content="black" />
+
     <meta http-equiv="Cache-Control" content="no-siteapp" /><!-- 不让百度转码 -->
    <!-- 设置苹果工具栏颜色:默认值为 default,可以定为 black和 black-translucent-->
+
     <meta name="HandheldFriendly" content="true"><!-- 针对手持设备优化,主要是针对一些老的不识别viewport的浏览器,比如黑莓 -->
     <meta http-equiv="Cache-Control" content="no-siteapp" />
+
     <meta name="MobileOptimized" content="320"><!-- 微软的老式浏览器 -->
    <!-- 不让百度转码 -->
+
     <meta name="screen-orientation" content="portrait"><!-- uc强制竖屏 -->
     <meta name="HandheldFriendly" content="true">
+
     <meta name="x5-orientation" content="portrait"><!-- QQ强制竖屏 -->
    <!-- 针对手持设备优化,主要是针对一些老的不识别viewport的浏览器,比如黑莓 -->
+
     <meta name="browsermode" content="application"><!-- UC应用模式 -->
     <meta name="MobileOptimized" content="320">
+
     <meta name="x5-page-mode" content="app"><!-- QQ应用模式 -->
    <!-- 微软的老式浏览器 -->
+
     <meta name="msapplication-tap-highlight" content="no"><!-- windows phone 点击无高光 -->
     <meta name="screen-orientation" content="portrait">
+
     <title>Team:XMU-China/Results - 2018.igem.org</title>
    <!-- uc强制竖屏 -->
+
     <link rel="stylesheet" href="css/description.css">
     <meta name="x5-orientation" content="portrait">
+
    <!-- QQ强制竖屏 -->
+
     <meta name="browsermode" content="application">
+
    <!-- UC应用模式 -->
+
     <meta name="x5-page-mode" content="app">
+
    <!-- QQ应用模式 -->
+
     <meta name="msapplication-tap-highlight" content="no">
+
    <!-- windows phone 点击无高光 -->
+
     <title>Team:XMU-China/Human Practices - 2018.igem.org</title>
+
     <link rel="stylesheet" href="css/Experiments.css">
+
    <link rel="stylesheet" href="css/font.css">
+
 
     <link href="http://cdn.bootcss.com/font-awesome/4.7.0/css/font-awesome.min.css" rel="stylesheet">
 
     <link href="http://cdn.bootcss.com/font-awesome/4.7.0/css/font-awesome.min.css" rel="stylesheet">
 
     <link rel="stylesheet" href="https://2018.igem.org/Team:XMU-China/css/cover?action=raw&ctype=text/css">
 
     <link rel="stylesheet" href="https://2018.igem.org/Team:XMU-China/css/cover?action=raw&ctype=text/css">
 
     <link rel="stylesheet" href="https://2018.igem.org/Team:XMU-China/css/footer?action=raw&ctype=text/css">
 
     <link rel="stylesheet" href="https://2018.igem.org/Team:XMU-China/css/footer?action=raw&ctype=text/css">
    <link rel="stylesheet" href="https://2018.igem.org/Team:XMU-China/css/font?action=raw&ctype=text/css">
 
 
     <link rel="stylesheet" href="https://2018.igem.org/Team:XMU-China/css/nav?action=raw&ctype=text/css">
 
     <link rel="stylesheet" href="https://2018.igem.org/Team:XMU-China/css/nav?action=raw&ctype=text/css">
 
     <link rel="stylesheet" href="https://2018.igem.org/Team:XMU-China/css/nav_mobile?action=raw&ctype=text/css">
 
     <link rel="stylesheet" href="https://2018.igem.org/Team:XMU-China/css/nav_mobile?action=raw&ctype=text/css">
 +
    <link rel="stylesheet" href="https://2018.igem.org/Team:XMU-China/css/description?action=raw&ctype=text/css">
 +
    <link rel="stylesheet" href="https://2018.igem.org/Team:XMU-China/css/font?action=raw&ctype=text/css">
 
     <link rel="stylesheet" href="https://2018.igem.org/Team:XMU-China/css/material-scrolltop?action=raw&ctype=text/css">
 
     <link rel="stylesheet" href="https://2018.igem.org/Team:XMU-China/css/material-scrolltop?action=raw&ctype=text/css">
    <link rel="stylesheet" href="https://2018.igem.org/Team:XMU-China/css/experiments?action=raw&ctype=text/css">
 
    <script src="js/jquery-1.11.0.min.js" type="text/javascript"></script>
 
    <script src="https://2018.igem.org/Team:XMU-China/js/bootstrap?action=raw&ctype=text/javascript"></script>
 
 
</head>
 
</head>
  
Line 129: Line 116:
 
         </header>
 
         </header>
 
     </div>
 
     </div>
     <script src="https://2018.igem.org/Team:XMU-China/js/hc-mobile-nav?action=raw&amp;ctype=text/javascript"></script>
+
    <script src="js/jquery-1.11.0.min.js"></script>
 +
    <!-- <script src="js/hc-mobile-nav.js"></script> -->
 +
     <script src="https://2018.igem.org/Team:XMU-China/js/hc-mobile-nav?action=raw&ctype=text/javascript"></script>
 
     <div class="header">
 
     <div class="header">
 
         <div class="logo">
 
         <div class="logo">
Line 213: Line 202:
 
         <div class="clear"></div>
 
         <div class="clear"></div>
 
         <div class="description_banner">
 
         <div class="description_banner">
             <div class="word">Human Practices</div>
+
             <div class="word">Results</div>
 
         </div>
 
         </div>
         <div class="Experiments hp">
+
         <nav class="Quick-navigation">
             <section id="Overview" class="js-scroll-step">
+
             <div class="Quick-navigation_word">
                 <div class="container">
+
                <img  src="https://static.igem.org/mediawiki/2018/f/f5/T--XMU-China--right0.png">
                     <div class="row">
+
                 <a href="#ABCDsystem" class="Quick-navigation-item">
                        <div class="col-md-offset-3 col-md-6">
+
                     <img id="turn_img" src="https://static.igem.org/mediawiki/2018/d/db/T--XMU-China--right1.png">
                            <div class="exp_name">Overview</div>
+
                    <a href="#ABCDsystem"id="Quick_A">ABCDsystem</a></a>
                            <div id="accordion">
+
                <a href="#OMVs" class="Quick-navigation-item" >
                                <div id="collapse0" class="panel-collapse collapse in" role="tabpanel">
+
                    <img id="turn_img" src="https://static.igem.org/mediawiki/2018/c/cd/T--XMU-China--right2.png">
                                    <div class="panel-body">
+
                    <a href="#OMVs" id="Quick_B">OMVs</a></a>
                                        <p> This year team XMU-China developed cell-free systems to detect and treat diseases. Protein detection is unique and significant in biology fields, especially for the detection of protein biomarkers which produced by diseased cells. In order to overcome the deficiencies of traditional detection methods, we have developed an Aptamer Based Cell-free Detection system (ABCD system) of protein. The core of the ABCD system is the specific binding of the aptamer and its target protein. After protein detection, we use outer-membrane vesicles (OMVs) to treat the diseased cells. We designed a system that has realized the efficient, customizable production of OMVs, which serves to encapsulate specific siRNA for disease treatment. To guarantee the practicability detection and treatment system, we also improved KaiABC system and TDPs system to regulate the expression rate of OMVs and store fragile chemicals or biological materials.</p>
+
                <a href="#Supporting" class="Quick-navigation-item">
                                        <p>
+
                    <img id="turn_img" src="https://static.igem.org/mediawiki/2018/1/1c/T--XMU-China--right3.png">
                                            In order to equip our idea with social demands, we have been practicing all through our project by conducting investigation on diseases detection and corresponding information, visiting biotechnology company to gain a better knowledge about the diseases detection, interacting with public to propagate synthetic biology and learning from teams applied themselves in diseases detection theme. We divided these activities in four stages which are Laws and Regulations, Inspiration and Reality, Public and Promotion, Idea and Wisdom, respectively. We have completed Human Practices silver medal criteria, <strong>Human Practices gold medal criteria/ Best Integrated Human Practices award and Best Education</strong> and <strong>Public Engagement award.</strong>
+
                    <a href="#Supporting" id="Quick_C">Supporting</a></a>
                                        </p>
+
            </div>
                                        <p class="F2"><img src="https://static.igem.org/mediawiki/2018/5/50/T--XMU-China--hp-overview.png"></p>
+
        </nav>
                                            <p>In addition,during human practice activities, we found that most disease-diagnosing methods are confined to specific delicate testing apparatus, which are expensive, time-consuming and low sensitivity. The study of Point-of-care testing (POCT), also called bedside testing (with the definition of medical diagnostic testing at or near the time and place of patient care), has become very heated because of its convenience, simplicity and highly efficiency. Internet of things (IoT) is the network of physical devices, vehicles, home appliances, and other items embedded with electronics, software, sensors, actuators, and connectivity which enables the connection and exchange of data.</p>
+
        <div class="main">
                                            <p>Here we came up with a design. We combined the idea of our project-Aptamer-based Cell-free Detection system (ABCD system), IoT, and the above concept of POCT so as to develop a microfluidic device, which is small while convenient for real-time detection of cancer. To see <a class="click_here" href="https://2018.igem.org/Team:XMU-China/Hardware">the Hardware</a> and <a href="https://static.igem.org/mediawiki/2018/d/dd/T--XMU-China--XMU-China_Enterprenureship.PDF"><span class="downloadpdf">XMU-China_Enterprenureship.pdf</span></a>.</p>
+
            <section id="ABCDsystem" class="js-scroll-step">
                                    </div>
+
                <div class="headline">
                                 </div>
+
                    The result of ABCD system
                             </div>
+
                </div>
                         </div>
+
                <h1>What work we've done:</h1>
 +
                <P>Verified the concept of our design for three modules respectively.</P>
 +
                <p>Verified the activity of EpCAM.</p>
 +
                <p>Verified the successful combination between SYL3C aptamer and EpCAM.</p>
 +
                <p>Verified that SYL3C aptamer could combine with 10nt complementary chain successfully.</p>
 +
                <p>Verified the feasibility of “competition method” successfully.</p>
 +
                <p>Verified that As Cas12a could be activated.</p>
 +
                <p>Verified the trans-cleavage activity.</p>
 +
                <p>Transferred molecular signal to fluorescence signal with DNase Alert.</p>
 +
                <p>Verified the transfer from protein signal to the fluorescent one successfully</p>
 +
                <h1>The work hasn’t finished yet:</h1>
 +
                <p>Quantitative analysis of the effect of "competition method" and "As Cas12a system" respectively</p>
 +
                <p>Verified the detection limit of "competition method", "As Cas12a system", and then our whole system</p>
 +
                <p>Other designs to transfer signals for reporting devices</p>
 +
                <h1>Activity of EpCAM (Flow cytometry)</h1>
 +
                <p> We got EpCAM directly from ACROBiosystems. In order to prove that the protein was still bio-active, we chose antibody of EpCAM with fluorescence and flow cytometry to measure it. Furnished by the research group laboratory, the fluorescence antibody was proved effective through previous experiments.</p>
 +
                <p>We bought EpCAM with His-tag tag. It’s widely known that His-tag could chelate with nickel ions, so we incubated EpCAM protein with nickel beads to bind them together. Adding the antibody and then incubating, we measured them with flow cytometry. At the same time, we started two other control group experiments, with the result shown below. Get more information of our experiment, <a class="click_here" href="https://2018.igem.org/Team:XMU-China/Experiments">click here.</a></p>
 +
                <p class="F2"><img src=" https://static.igem.org/mediawiki/2018/6/66/T--XMU-China--measurement-1017_7.png"></p>
 +
                    <div class="table_container">
 +
                        <table class="table">
 +
                            <tr>
 +
                                <th>Name</th>
 +
                                <th>Events</th>
 +
                                <th>% Parent</th>
 +
                                <th>% Grandparent</th>
 +
                                <th>% Total</th>
 +
                                <th>PE-A Mean</th>
 +
                                <th>PE-A Geo Mean</th>
 +
                            </tr>
 +
                            <tr>
 +
                                <td>ni-beads:P1</td>
 +
                                <td>5,087</td>
 +
                                <td>94.52</td>
 +
                                <td>***</td>
 +
                                <td>94.52</td>
 +
                                <td>108</td>
 +
                                 <td>82</td>
 +
                             </tr>
 +
                            <tr>
 +
                                <td>ni-beads+antiepcam:P1</td>
 +
                                <td>5,208</td>
 +
                                <td>91.45</td>
 +
                                <td>***</td>
 +
                                <td>91.45</td>
 +
                                <td>2,880</td>
 +
                                <td>2,626</td>
 +
                            </tr>
 +
                            <tr>
 +
                                <td>EpCAM+Anti-EpCAM:P1</td>
 +
                                <td>4,238</td>
 +
                                <td>93.53</td>
 +
                                <td>***</td>
 +
                                <td>93.53</td>
 +
                                <td>14,816</td>
 +
                                <td>14,211</td>
 +
                            </tr>
 +
                         </table>
 
                     </div>
 
                     </div>
                </div>
+
                    <p>
            </section>
+
                        <p class="Figure_word"><strong>Figure 1</strong>: the result of detecting the binding of EpCAM with fluorescent antibody, with flow cytometry. <br>
            <section id="Competition_experiment" class="js-scroll-step">
+
                            a) Black line: pure nickel beads; <br>b) Blue line: nickel beads + fluorescent antibody (measure the non-specific adsorption between beads and antibody); <br>c) Red line: nickel beads - EpCAM complex + fluorescence antibody.
                <div class="container">
+
                        </p>
                     <div class="row">
+
                     </p>
                        <div class="col-md-offset-3 col-md-6">
+
                    <p> From the graph and data above, we could find out that the non-specific adsorption between nickel beads and fluorescent antibody does exist, but in the presence of EpCAM, the fluorescence intensity increased seven times compared with the original one, so we could prove that our bio-active EpCAM protein successfully combined with fluorescent antibody.</p>
                            <div class="exp_name">Sliver</div>
+
                    <h1>Combination between SYL3C and EpCAM (fluorescence polarization)</h1>
                        </div>
+
                    <p> Although EpCAM and aptamer SYL3C are directly quoted in the literature <sup>[1]</sup>, we believed that we still needed to verify this step and that we could ensure the validity of our material.</p>
                        <div id="accordion">
+
                    <p>We struggled with this step for a long period, and we suspected that our failure was caused by impure materials. We used 30KDa ultrafiltration tube - through which unbound fluorescent aptamers could pass, but the aptamer combined with protein could not. We also used flow cytometry to directly detect whether there were binding fluorescent aptamers on EpCAM, without satisfying results in the end. </p>
                            <div class="expstep_name">Inspiration and Reality</div>
+
                    <p>
                            <div class="panel">
+
                        Fortunately, we successfully validated this step with the fluorescence polarization method after replacing materials, with the proposal from Prof. Zhi Zhu. We incubated two groups, namely pure fluorescence aptamers as well as fluorescent aptamers with EpCAM without light at the same time, then adding binding buffer to the total volume of 200μL. After incubation, we added 3mL binding buffer for fluorescence polarization. Get more information of our experiment, <a class="click_here" href="https://2018.igem.org/Team:XMU-China/Experiments">click here.</a>
                                <div id="collapse11-1" class="panel-collapse collapse in" role="tabpanel">
+
                    </p>
                                    <div class="panel-body no_top">
+
                    <p class="F6"><img src="https://static.igem.org/mediawiki/2018/e/e2/T--XMU-China--result1-2.png">
                                        <p class="com"> Creating a brainstorm is simplified, how to put theory into practice matters more. For understanding diseases detection reality socially, we visited three organizations, which all have authority background in Xiamen area. In order to consider the feasibility of the ABCD system in our project, we interviewed Prof. ZhiZhu who has very fruitful results on aptamers, the Chief Physician Weiwei Tang and Prof. Zengfu Xue. We finally visited a grass-roots Health Service Center to find our product’s market positioning.</p>
+
                        <p class="Figure_word"><strong>Figure 2.1:</strong> polarizing fluorescence intensity of fluorescence aptamer.</p>
                                    </div>
+
                    </p>
                                </div>
+
                    <p class="F6"><img src="https://static.igem.org/mediawiki/2018/b/b9/T--XMU-China--result1-3.png">
                            </div>
+
                        <p class="Figure_word"><strong>Figure 2.2:</strong> polarizing fluorescence intensity of fluorescent aptamers with EpCAM, after incubation.</p>
                            <div class="panel">
+
                    </p>
                                <div class="panel-heading" role="tab" id="heading114-1">
+
                    <p> According to the principle of fluorescence polarization, the FP value would depend directly on the effective molecular size of the fluorescent group at fixed temperature and viscosity of solution. For small molecules (fluorescent aptamers) with fast Brownian rotation in solution, the FP value was lower; while for larger molecules (fluorescent aptamers combined with EpCAM), the FP value was higher. <sup>[2]</sup></p>
                                    <h4 class="panel-title">
+
                    <p> The FP value could be calculated by the following formula: </p>
                                <a class="collapsed" role="button" data-toggle="collapse" data-parent="#accordion" href="#collapse114-1" aria-expanded="false" aria-controls="collapse114-1">
+
                    <p class="center"><img src="https://static.igem.org/mediawiki/2018/a/a2/T--XMU-China--result1-4.png"></p>
                                    Visiting INNOVAX
+
                        <p>Below are four maximum fluorescence values for calculating FP values:</p>
                                </a>
+
                        <p class="center"><img src="https://static.igem.org/mediawiki/2018/3/3b/T--XMU-China--result1-5.png"></p>
                            </h4>
+
                            <p class="center"><img src="https://static.igem.org/mediawiki/2018/f/fb/T--XMU-China--result1-6.png"></p>
                                </div>
+
                                <p>Later, we could calculate whether the FP value of fluorescent aptamers increased with EpCAM incubation according to the principle. If the FP value increased, it showed that fluorescent aptamers did bind to EpCAM. We calculated the difference herein:</p>
                                 <div id="collapse114-1" class="panel-collapse collapse" role="tabpanel">
+
                                 <p class="center"><img src="https://static.igem.org/mediawiki/2018/1/11/T--XMU-China--result1-7.png"></p>
                                    <div class="panel-body">
+
                                    <p>With an increase of 0.142, the difference was rather obvious, which demonstrated that the fluorescent aptamer did combine with EpCAM.</p>
                                        <p> On the afternoon of July 9<sup>th</sup>, accompanied by a line of people,Haifei Xu, the technical director of the Wan-Thai Biological Pharmaceutical Co., Ltd., XMU_CHINA team visited to Xiamen INNOVAX Biotech Co., Ltd., Xiamen InnoDx Biotech Co., Ltd.to study. </p>
+
                                    <h1>Combination between SYL3C and the “complementary chain” (DNA agarose gel electrophoresis)</h1>
                                        <p>The first stop, Xiamen InnoDx Biotech Co., Ltd. According to the company's representative, this company is a wholly-owned subsidiary of the YOSEIDO's Wan-Thai bio-Pharmaceutical Co., Ltd., focusing on the development, production and sales of automatic tubular chemiluminescence immunoassay reagents and bioactive raw materials.
+
                                    <p> We've been struggling for some time due to one problem about how to prove that our aptamers and the complementary chains were combined, which would be paramount for our following experiments.</p>
 +
                                    <p> We tried SYBR Green I, a fluorescent dye that could be embedded in a double helix of DNA and thus significantly enhance fluorescence intensity, since it could distinguish ssDNA from dsDNA obviously. However, there's no significant difference according to our results. We speculated that the sequence might be not long enough, coupled with the formation of secondary structure of aptamers, leading to no difference in fluorescence intensity.</p>
 +
                                    <p> Finally, we exploited the conventional gel electrophoresis method to prove this block, and then gel electrophoresis was performed immediately after grouping and denaturing annealing. Because the sequence was too short, we did not have the appropriate DNA marker to use. Get more information of our experiment, <a class="click_here" href="https://2018.igem.org/Team:XMU-China/Experiments">click here.</a></p>
 +
                                    <p class="F25"><img src="https://static.igem.org/mediawiki/2018/6/62/T--XMU-China--result1-8.png">
 +
                                        <p class="Figure_word"><strong>Figure 3:</strong> gel image of aptamer combined with complementary chain.<br>
 +
                                            a) W1: aptamer;<br> b) W2: 24nt complementary chain with a 9nt complementary part; <br>c) W3: 24nt complementary chain with a 10nt complementary part;<br> d) W4: Aptamer+ 24nt complementary chain with a 9nt complementary part; <br>e) W5: Aptamer+ 24nt complementary chain with a 10nt complementary part;
 
                                         </p>
 
                                         </p>
                                        <p>The next stop, Xiamen INNOVAX Biotech Co., Ltd. The same, it is also a wholly-owned subsidiary of the Wan-Thai Bio-Pharmaceutical Co., Ltd., which is committed to providing high quality and affordable innovative vaccines to the public for human disease prevention. Since its inception in 2005, the corporation has successfully listed the world's first vaccine to against HEV.</p>
+
                                    </p>
                                        <p class="F3"><img src="https://static.igem.org/mediawiki/2018/2/2f/T--XMU-China--Entrepreneurship-5.png"></p>
+
                                    <p>We could find that there were three distinct bands between the aptamer + complementary chains with a 10nt complementary part (W5), while 9nT did not. The lane 1 and 2 acted as markers, so we could clearly identify the positions of the aptamers and complementary chains in the three bands. The last band, obviously, was the result of an increase in molecular weight, which meant that the aptamer and the complementary chain combined together successfully.</p>
                                     </div>
+
                                    <p>Therefore, we have proved that the aptamer could combine with its complementary chain successfully.</p>
                                </div>
+
                                     <h1>The competition (Spectrofluorometer)</h1>
                            </div>
+
                                     <p> We used the competition method to transfer molecular signal, because we considered that the competition method was best operated automatically later, so that users did not need to have a deep understanding toward technical basis. Therefore, it's quite important for us to verify that EpCAM could compete successfully, from a theoretical prospective to support our hardware and the activation of Cas12a as well.</p>
                            <div class="panel">
+
                                    <p> Below are the exact procedures of our experimental group. First, we successfully hatched the streptavidin beads, biotin-modified aptamers and fluorescent complementary chains to form the complexes, then fixed the beads with magnets and discarded the supernatant, which would still contain fluorescent complementary chains that did not form complexes. After that, we incubated the complex with EpCAM to achieve the process of competition.</p>
                                <div class="panel-heading" role="tab" id="heading114_1_1">
+
                                    <p> Additionally, considering the non-specific adsorption, we set up several control groups, and the variables amongst them were replaced by buffer. After competition, we fixed the magnetic beads with magnet, then extracted the supernatant and added 3mL incubation buffer in tandem. Below is the plot about the fluorescence intensity detected in different groups. Get more information of our experiment, <a class="click_here" href="https://2018.igem.org/Team:XMU-China/Experiments">click here.</a></p>
                                     <h4 class="panel-title">
+
                                    <p class="F6"><img src="https://static.igem.org/mediawiki/2018/3/37/T--XMU-China--result1-9.png">
                                <a class="collapsed" role="button" data-toggle="collapse" data-parent="#accordion" href="#collapse114_1_1" aria-expanded="false" aria-controls="collapse114_1_1">
+
                                        <p class="Figure_word"><strong>Figure 4:</strong> fluorescence intensity images of competition results <br>a) Black line: incubation buffer; <br>b) Red line: magnetic beads - aptamer + incubation buffer; <br>c) Blue line: magnetic beads - aptamer - complementary chain complex + incubation buffer; <br>d) Green line: magnetic beads - aptamer - complementary chain complex + EpCAM + incubate buffer.
                                    Visiting Mr. Minglue Su, founder and chairman of Xiamen Kymem Membrane Technology Ltd.
+
                                </a>
+
                            </h4>
+
                                </div>
+
                                <div id="collapse114_1_1" class="panel-collapse collapse" role="tabpanel">
+
                                    <div class="panel-body">
+
                                        <p>On September 30<sup>th</sup> 2018, we visited Mr. Su, founder and chairman of Xiamen Kymem Membrane Technology Ltd, to have a deep discussion about information related to enterprises. He shared with us his experience of setting-up a new company, and rendered us prepared for drawing up business plans. </p>
+
                                        <p>In the view of Mr. Su, having a sufficient knowledge about not only your company, but your competitors’ on the basis of market analysis was the premise of drawing up a good business plan. The business plan should involve some basic parts, namely the company’s technology introduction, market potential demand, market actual demand, team composition and competitive team analysis. We introduced our project, which joined competition this year, to Mr. Su, and highlighted the hardware products which we independently developed. Mr. Su expressed his expectation for the potential of our hardware equipment in the medical field. But on the other hand, given that starting a new business is tough, Mr. Su believed that our team would encounter five “new” threats in the initial stage, that is, new team, new cooperation partners, new capital, new technologies and new customers.</p>
+
                                        <p>He also mentioned that at the initial period of our business, not only the company’s internal developing problems, but also the constrictions of the external environment would be the obstacle. Referring to his personal accumulated experience, Mr. Su further gave us some suggestions targeting on starting a new business: considering that China’s current intellectual property law system was still imperfect, innovative companies, like ours, who were known for their technological advantages must emphasize the patent-protection. What’s more, when our brand was still not so influential compared to those prestigious companies, we should put seeking target customers and broadening sales channels on the front burner, and carefully prevent our technology property right from being infringed. On top of that, he proposed that since our hardware product was based on the "government + grassroots + personal" operation mode, it was necessary to work hard in marketing, with clear targets and strategies.</p>
+
                                        <p class="F3"><img src="https://static.igem.org/mediawiki/2018/c/c5/T--XMU-China--Entrepreneurship-7.png"></p>
+
                                    </div>
+
                                </div>
+
                            </div>
+
                            <div class="panel">
+
                                <div class="panel-heading" role="tab" id="heading115_1_1">
+
                                    <h4 class="panel-title">
+
                                <a class="collapsed" role="button" data-toggle="collapse" data-parent="#accordion" href="#collapse115_1_1" aria-expanded="false" aria-controls="collapse115_1_1">
+
                                    Visiting Mr. Jianghong Wu, founder of Xiamen Wenda Technology Ltd.
+
                                </a>
+
                            </h4>
+
                                </div>
+
                                <div id="collapse115_1_1" class="panel-collapse collapse" role="tabpanel">
+
                                    <div class="panel-body">
+
                                        <p>
+
                                            We visited Mr. Jianghong Wu, president of Xiamen Wenda technology LTD. We had an enjoyed communication with Mr. Wu, which is about the communication mode between team hardware and software and the practicability of software design. We introduced the general situation of this year's team project to Mr. Wu, and emphasized the original intention of the team to solve the "aerial phenomenon" of the current "graded diagnosis and treatment" policy, as well as the difficulty in getting medical treatment in remote areas. Mr. Wu fully affirmed the innovative project and praised the team consciousness of social responsibility.
+
 
                                         </p>
 
                                         </p>
                                        <p>As for APP part he gave some professional advices and technical guidance, like how to accelerate our convolution neural network recognition speed with collected increasing number of images cases, and how to link block them up between chain technology public health service database to serve the public better. In addition, Mr. Wu gave us a lot of advice on product promotion and profit model.</p>
+
                                    </p>
                                        <p class="F3"><img src="https://static.igem.org/mediawiki/2018/8/83/T--XMU-China--Entrepreneurship-9.png"></p>
+
                                     <p>Comparing the four groups, we can conclude that the non-specific adsorption of complementary chains on the magnetic beads does exist, and the magnetic bead-aptamer complex, like the buffer solution, had almost no fluorescence. Significantly, the fluorescence intensity of the competition group with EpCAM was about 2.5 times larger than that of the non-specific adsorption group, which demonstrated that the fluorescence complementary chain of the competition group with EpCAM was successful, and so was our competition method.</p>
                                     </div>
+
                                     <h1>Trans-cleavage activity of Cas12a (Microplate Reader)</h1>
                                </div>
+
                                     <p>It's reported that cas12a could be activated by ssDNA and has trans-cleavage activity this year, so we hope to use this function in our system to amplify the signal. <sup>[3]</sup></p>
                            </div>
+
                                     <p>We operated the experiment according to the instructions from IDT. We incubated the cas12a protein with crRNA to form a complex and then added our ssDNA to be recognized. Then, we used the commercial DNase Alert Kit to explore its trans-cleavage activity. We drawed the fluorescence curve with time using a microplate reader, and measured the fluorescence from 30 minutes to 110 minutes</p>
                            <div class="panel">
+
                                    <p>In order to control variables, we also set up a negative (DNase Alert) and a positive (DNase I + DNase Alert) control group. Get more information of our experiment, <a class="click_here" href="https://2018.igem.org/Team:XMU-China/Experiments">click here.</a></p>
                                <div class="panel-heading" role="tab" id="heading115_1_1_1">
+
                                     <p class="F6"><img src="https://static.igem.org/mediawiki/2018/d/df/T--XMU-China--result1-10.png">
                                    <h4 class="panel-title">
+
                                        <p class="Figure_word"><strong>Figure 5:</strong> ffluorescence time curve image of activation effect of cas12a <br>a) Black line: negative group, DNase Alert only; <br>b) Red line: positive group, DNase I + DNase Alert; <br>c) Blue line: experimental group, activated cas12a+DNase Alert;
                                <a class="collapsed" role="button" data-toggle="collapse" data-parent="#accordion" href="#collapse115_1_1_1" aria-expanded="false" aria-controls="collapse115_1_1_1">
+
                                    Interviewing Prof. Zhi Zhu
+
                                </a>
+
                            </h4>
+
                                </div>
+
                                <div id="collapse115_1_1_1" class="panel-collapse collapse" role="tabpanel">
+
                                    <div class="panel-body">
+
                                        <p>
+
                                            In order to consider the feasibility of the ABCD system in our project, we interviewed Prof. Zhi Zhu of the College of Chemistry and Chemical Engineering of Xiamen University on May 2, and she has very fruitful results on aptamers. </p>
+
                                        <p>The professor affirmed the feasibility of our project and gave us some invaluable advice. Under the suggestion of Prof. Zhi Zhu, we chose EpCAM and aptamer SYL3C. In addition, we are very grateful to Prof. Zhu for her support on many instruments and materials provided during our experiments.</p>
+
                                        <p class="F3"><img src="https://static.igem.org/mediawiki/2018/8/8d/T--XMU-China--hp-zhuzhi.png"></p>
+
                                     </div>
+
                                </div>
+
                            </div>
+
                            <div class="panel">
+
                                <div class="panel-heading" role="tab" id="heading115_21">
+
                                    <h4 class="panel-title">
+
                                <a class="collapsed" role="button" data-toggle="collapse" data-parent="#accordion" href="#collapse115_21" aria-expanded="false" aria-controls="collapse115_21">
+
                                    Consulting the Chief Physician Weiwei Tang in Medical Oncology
+
                                </a>
+
                            </h4>
+
                                </div>
+
                                <div id="collapse115_21" class="panel-collapse collapse" role="tabpanel">
+
                                     <div class="panel-body">
+
                                        <p>
+
                                            IThis year,team XMU-China developed new methods named ABCD System and OMVs Treatment for detecting and treating diseases. In order to prove the feasibility of our project, we consulted the Chief Physician Weiwei Tang in Medical Oncology, The First Affiliated Hospital of Xiamen University, on August 23th. We introduced briefly the structure and function of our self-designed hardware <i>Fang</i> to Dr. Tang. During the talk, Dr. Tang appreciated it that our ideas are innovative and helpful. What’s more, Dr. Tang also told us those frequently-used and classical clinical detection methods, like ELISA, CLIA and so on. Most of which are time-consuming, expensive and complex, compared with <i>Fang</i>. As for <i>Fang</i>, Dr. Tang agreed with our proposals that we are going to make <i>Fang</i> widely used among basic medical institutions, especially in remote, and poverty-stricken areas because of its convenient and practicability. But it’s worth noting that today there is an authoritative method for disease-diagnose, i.e., pathological diagnosis. So our detection method would just serve as a kind of screening tool rather than diagnosis method, according to Tang’s suggestion.</p>
+
                                        <p>The professor affirmed the feasibility of our project and gave us some invaluable advice. Under the suggestion of Prof. Zhi Zhu, we chose EpCAM and aptamer SYL3C. In addition, we are very grateful to Prof. Zhu for her support on many instruments and materials provided during our experiments.</p>
+
                                        <p class="F3"><img src="https://static.igem.org/mediawiki/2018/9/9f/T--XMU-China--Entrepreneurship-6.png"></p>
+
                                     </div>
+
                                </div>
+
                            </div>
+
                            <div class="panel">
+
                                <div class="panel-heading" role="tab" id="heading115_22">
+
                                    <h4 class="panel-title">
+
                                <a class="collapsed" role="button" data-toggle="collapse" data-parent="#accordion" href="#collapse115_22" aria-expanded="false" aria-controls="collapse115_22">
+
                                    Visiting Prof. Zengfu Xue
+
                                </a>
+
                            </h4>
+
                                </div>
+
                                <div id="collapse115_22" class="panel-collapse collapse" role="tabpanel">
+
                                    <div class="panel-body">
+
                                        <p>
+
                                            We visited Prof. Zengfu Xue, deputy director of the Cancer Early Screening Diagnosis and Treatment Center, the First Affiliated Hospital of Xiamen University. We exchanged and discussed with Prof. Xue about the design of cell free detection system of tumor markers and detection carrier of microfluidic chip. Prof. Xue fully affirmed the innovation and feasibility of this project, and appreciated the original intention of the team to solve the problem of difficult access to medical services in large hospitals, which helped to improve the current "hierarchical diagnosis and treatment" policy system to some extent. We communicated with Prof. Xue about the next clinical trial plan of the detection hardware <i>Fang</i>, and reached a preliminary cooperation agreement. If possible, we could take the instrument to the lab in hospital, and use the patient's blood sample to verify the performance of the instrument, such as stability and sensitivity.</p>
+
                                        <p class="F3"><img src="https://static.igem.org/mediawiki/2018/e/e7/T--XMU-China--Entrepreneurship-8.png"></p>
+
                                            <p class="F3"><img src="https://static.igem.org/mediawiki/2018/6/64/T--XMU-China--hp-%3Di.png"></p>
+
                                    </div>
+
                                </div>
+
                            </div>
+
                            <div class="panel">
+
                                <div class="panel-heading" role="tab" id="heading115_23">
+
                                    <h4 class="panel-title">
+
                                <a class="collapsed" role="button" data-toggle="collapse" data-parent="#accordion" href="#collapse115_23" aria-expanded="false" aria-controls="collapse115_23">
+
                                    Visiting a grass-roots Health Service Center
+
                                </a>
+
                            </h4>
+
                                </div>
+
                                <div id="collapse115_23" class="panel-collapse collapse" role="tabpanel">
+
                                     <div class="panel-body">
+
                                        <p>
+
                                            We visited Health Service Center of Datong Street, Tong’an District, Xiamen city. We learned about the development of tumor markers detection work in primary hospitals from director Zhan. We found that primary hospitals were mostly able to carry out screening of basic tumor markers such as alpha fetoprotein. If people want to carry out more systematic and specific tumor screening, they had to be referred to higher-level hospitals. In addition, due to the implementation effect of China's medical security system and Xiamen's health policy, the screening of tumor markers at the grassroots-level health center could save about 50% of the cost compared with the large hospitals. Therefore, to sum up, president Zhan affirmed the future prospects of our instruments, believing it would solve problems such as "difficult access to medical services" in real life, to better provide more convenient medical and health services.</p>
+
                                        <p class="F3"><img src="https://static.igem.org/mediawiki/2018/c/cf/T--XMU-China--Entrepreneurship-10.png"></p>
+
                                    </div>
+
                                </div>
+
                            </div>
+
                            <div class="expstep_name">Laws and Regulations</div>
+
                            <div class="panel">
+
                                <div class="panel-heading" role="tab" id="heading113_1">
+
                                    <h4 class="panel-title">
+
                                <a class="collapsed" role="button" data-toggle="collapse" data-parent="#accordion" href="#collapse113_1" aria-expanded="true" aria-controls="collapse113_1">
+
                                    Advanced Policies in POCT field
+
                                </a>
+
                            </h4>
+
                                </div>
+
                                <div id="collapse113_1" class="panel-collapse collapse" role="tabpanel">
+
                                    <div class="panel-body">
+
                                        <p>The medical reform policies, together with the reasonable superintendence will promote the rapid progress of POCT(point-of-care testing) in America.
+
 
                                         </p>
 
                                         </p>
                                        <p class="F3"><img src="https://static.igem.org/mediawiki/2018/d/d7/T--XMU-China--hp-111i.png">
+
                                    </p>
 
+
                                    <p>We fitted three sets of data points with Gaussian fitting curve in Figure 5. From the fitting results, we could see that the negative group and the positive group were declining, while the cas12a proteome increased at first and then decreased. This is in line with our expectations, and the reason for the decline was, we suspected, the quenching caused by continuous measurements and the weakening of the fluorescence itself as the experiment proceeds. However, it's enough to prove that cas12a could meet the expected result of amplifying signals.</p>
 +
                                    <h1>Signal transformation by DNase Alert (Spectrofluorometer)</h1>
 +
                                    <p> Although we have used DNase alert to detect Cas12a, as the last of the three modules we designed, we needed to prove that DNase alert was indeed cut and would emit fluorescence to our expectations, so that it could be used to transfer our signals.</p>
 +
                                    <p> Here, we chose DNase I to verify directly. In the presence or absence of DNase I, we measured fluorescence intensity in the DNase alert tube. Considering the experiences we got previously that long-term measurement in the microplate reader would lead to reduction in fluorescence intensity, resulting in experimental error, we chose spectrophotometer instead.</p>
 +
                                    <p> We set up the experimental group (with DNase I) and the control group (without DNase I), with the time gradient of 3, 15, 30 minutes. All groups started at the same time. We didn’t operate continuous measurement, to avoid excitation that may cause partial fluorescence quenching. After incubation, 3mL TE buffer was added, and then detect the fluorescence. Get more information of our experiment, <a class="click_here" href="https://2018.igem.org/Team:XMU-China/Experiments">click here.</a></p>
 +
                                    <p class="F6"><img src="https://static.igem.org/mediawiki/2018/d/dc/T--XMU-China--result1-11.png">
 +
                                        <p class="Figure_word"><strong>Figure 6:</strong> fluorescence intensity curve in 3rd minutes, with or without DNase I
 
                                         </p>
 
                                         </p>
                                            <p>America now is encountered with the payment pressures imposed by enormous medical insurance fees resulted from the aged tendency of population and the changes in the spectrum of diseases. According to the forecast by CBO, the expense of health products will reach up to 4,600 billion in 2020, accounting for 20% of the GDP. Besides, it was shown in the OECD report that in 2011, American people’s average expenditure on health care was up to 8233 dollars, twice the expenditure of comparatively developed European countries like French, Switzerland and England. In March, 2010, American president Barack Obama carried out the “Affordable Care Act”, aiming at improving the quality of American health insurance service, and decreasing the cost of health care service. The “ACA Act” established the balance sharing plan, which encouraged doctors and hospitals to meet the patients’ medical needs by an integral medical service system through encouraging accountable care organizations. Under that balance sharing plan, suppliers and organizers of the service who meet the standard set by US HHS can serve those who benefits from the medical insurance plan through co-organizing and coordinating. ACO could help reduce the cost and increase the efficiency, and distribute part of the surplus among members. Under the design of the ACO system, the new service supplying mode integrate hospitals, general practitioners, medical specialists and other specialists to answer for the medical quality and medical cost together.</p>
+
                                    </p>
                                            <p class="F3"><img src="https://static.igem.org/mediawiki/2018/7/78/T--XMU-China--hp-1222i.png">
+
                                    <p class="F6"><img src="https://static.igem.org/mediawiki/2018/b/b8/T--XMU-China--result1-12.png">
                                                <p class="Figure_word"><a class="click_here" href="https://www.aha.org/">Come from wiki</a></p>
+
                                        <p class="Figure_word"><strong>Figure 7:</strong> fluorescence intensity curve in 15th minutes, with or without DNase I
                                            </p>
+
                                            <p>In America, POCT is supervised by FDA, and is co-organized by certification authority, POCT committee, and POCT coordinators. It exists as one of the branches of IVD. Therefore, it is also supervised under the policies of medical apparatus and instruments. At the same time, IVD products are also supervised under CLIA 88 enacted in 1992, which divided IVD into three registering levels (low, medium and high) basing on the complexity of experiments. Before obtaining the right of market entrance, producers have to make appliances according to CLIA categorizing system. After that, CMS, DCLD and CDC will check the products and authorize corresponding CLIA certifications. When it comes to POCT products specially, they will have to firstly recognized by JCAHO and CAP, and finally authorize and certificate by JCAHO, CMS and CAP.</p>
+
                                            <p class="F3"><img src="https://static.igem.org/mediawiki/2018/9/92/T--XMU-China--hp-333.png">
+
                                                <p class="Figure_word"><a class="click_here" href="http://www.gf.com.cn/">Come from wiki</a></p>
+
                                            </p>
+
                                            <p>In terms of the usage of POCT products, owing to the fact that there is not much barrier, the superintendence is therefore the key to optimizing POCT and enlarging its range of application. POCT committees have been set in every organization, city and state in America so as to implement quality-superintendence over its usage and guarantee the accuracy of the testing results.</p>
+
                                            <p class="F3"><img src="https://static.igem.org/mediawiki/2018/8/81/T--XMU-China--hp-4444.png">
+
                                                <p class="Figure_word"><a class="click_here" href="https://www.fda.gov//">Come from wiki</a></p>
+
                                            </p>
+
                                    </div>
+
                                </div>
+
                            </div>
+
                            <div class="expstep_name">Public and Promotion</div>
+
                            <div class="panel">
+
                                <div id="collapse11-1" class="panel-collapse collapse in" role="tabpanel">
+
                                    <div class="panel-body no_top">
+
                                        <p class="com"> Working on synthetic biology in a lab is amazing, but sharing our enthusiasm can be even more wonderful. For the science education, we worked with people from all walks of life including teenagers, citizens, freshmen and XMU students.</p>
+
                                    </div>
+
                                </div>
+
                            </div>
+
                            <div class="panel">
+
                                <div class="panel-heading" role="tab" id="heading14">
+
                                    <h4 class="panel-title">
+
                                <a class="collapsed" role="button" data-toggle="collapse" data-parent="#accordion" href="#collapse14" aria-expanded="false" aria-controls="collapse14">
+
                                    Xiamen Science and Technology Museum
+
                                </a>
+
                            </h4>
+
                                </div>
+
                                <div id="collapse14" class="panel-collapse collapse" role="tabpanel">
+
                                    <div class="panel-body">
+
                                        <p>
+
                                            This year our team XMU-China came to Xiamen Science and Technology Museum to advocate the synthetic biology and our project. The whole project about 3 parts, game, Poster and Wish Wall. First, the game part, children play the roles of antibody and antigen respectively, they battled to be the winner by RPS. After the game they all left a deep impression of the general method that our body fight with cancer. Second,Poster,we had some talkative teammates to take charge of this part, so many student from high school and primary school were attracted ,they crowded in front of the poster and listened to our announcers absorbedly. Finally, the Wish Wall part, after our diverse introductions about the synthetic biology, they had learn a lot about it, and some of them even inspire to give their contributions to synthetic biology, and want to attend the innovative, fantastic competition —— iGEM. It’s also a cheerful Day for our team to propagate the synthetic biology to so many children.
+
 
                                         </p>
 
                                         </p>
                                        <p class="F3"><img src="https://static.igem.org/mediawiki/2018/d/d6/T--XMU-China--HP-part3-1.jpg"><img src="https://static.igem.org/mediawiki/2018/0/00/T--XMU-China--HP-part3-2.jpg"><img src="https://static.igem.org/mediawiki/2018/a/a3/T--XMU-China--HP-part3-3.jpg"></p>
+
                                    </p>
                                    </div>
+
                                    <p class="F6"><img src="https://static.igem.org/mediawiki/2018/3/3d/T--XMU-China--result1-13.png">
                                </div>
+
                                        <p class="Figure_word"><strong>Figure 8:</strong> fluorescence intensity curve in 30th minutes, with or without DNase I
                            </div>
+
                            <div class="panel">
+
                                <div class="panel-heading" role="tab" id="heading15_1">
+
                                    <h4 class="panel-title">
+
                                <a class="collapsed" role="button" data-toggle="collapse" data-parent="#accordion" href="#collapse15_1" aria-expanded="false" aria-controls="collapse15_1">
+
                                    Fighting for Mooncake —— A Special Activity in Mid-Autumn Festival
+
                                </a>
+
                            </h4>
+
                                </div>
+
                                <div id="collapse15_1" class="panel-collapse collapse" role="tabpanel">
+
                                    <div class="panel-body">
+
                                        <p>Fighting for Mooncake is a traditional activity spent with relatives or close friends in Xiamen area in order to celebrate the Mid-Autumn Festival. Throughout the game, we advertised the iGEM to freshmen, and introduced our project this year. It was worth mentioning that we also collected solicited opinions from all the students about the feasibility of our disease detective device and treatment device with cell-free system this year. 86.7% of participants showed positive attitudes towards our detective device, with the common sense of this device could performed pre-diagnosis quickly to guide patients. 66.8% students thought that it was difficult to treat tumors with vesicles, but it was very promising.
+
 
                                         </p>
 
                                         </p>
                                        <p class="F3"><img src="https://static.igem.org/mediawiki/2018/f/f8/T--XMU-China--HP-part3-4.jpg"><img src="https://static.igem.org/mediawiki/2018/7/7c/T--XMU-China--HP-part3-5.jpg"><img src="https://static.igem.org/mediawiki/2018/0/0f/T--XMU-China--HP-part3-6.jpg"><img src="https://static.igem.org/mediawiki/2018/3/38/T--XMU-China--HP-part3-7.jpg"></p>
+
                                    </p>
                                     </div>
+
                                    <p>From the Figure 6-8, we could find that cutting efficiency of DNase I was very high, almost all of the DNase Alert substrate has been cut in 3 minutes, fluorescence in 15 and 30 minutes and 3 minutes almost keep the same level. As we expected, DNase alert could indeed be cleaved and then re-released as a fluorescent group. In other words, DNase alert could transfer the molecular signal to the fluorescent signal actually.</p>
                                </div>
+
                                     <h1>Integrated experiment</h1>
                            </div>
+
                                     <p>After making each part work effectively, we accomplished the integrated experiment finally, transferring the protein signal to fluorescent one.</p>
                            <div class="panel">
+
                                    <p>Similarly, following procedures mentioned in the "competition method" part, we successfully hatched the streptavidin beads, biotin-modified aptamers and fluorescent complementary chains to form the complexes, then fixed the beads with magnets and discarded the supernatant, which would still contain fluorescent complementary chains that did not form complexes. After that, we incubated the complex with EpCAM to achieve the process of competition. After competition, we fixed the magnetic beads with magnet, adding the supernatant extracted into Cas12a-crRNA complex incubated previously to activate Cas12a protein. Finally, we added it into DNase Alert, supplementing 3mL TE buffer after 30 minutes to measure the fluorescent intensity. Below is the corresponding plot we've obtained, indicating that we made the integrated experiment successfully.</p>
                                <div class="panel-heading" role="tab" id="heading15-1">
+
                                    <p class="F6"><img src="https://static.igem.org/mediawiki/2018/5/5e/T--XMU-China--notebook-abcd-7.png">
                                     <h4 class="panel-title">
+
                                         <p class="Figure_word"><strong>Figure 9:</strong> Integrated experiment
                                <a class="collapsed" role="button" data-toggle="collapse" data-parent="#accordion" href="#collapse15-1" aria-expanded="false" aria-controls="collapse15-1">
+
                                   
+
                                    Visiting Yanwu Elementary School
+
                           
+
                                </a>
+
                            </h4>
+
                                </div>
+
                                <div id="collapse15-1" class="panel-collapse collapse" role="tabpanel">
+
                                    <div class="panel-body">
+
                                        <p>In order to popularize the common knowledge of biology to the public and meanwhile to draw the public attention to synthetic biology, this year we XMU-China team visited to Yanwu Elementary School, volunteering to teach elementary students biology, introducing our team and work, and directing them to do some simple biological experiments. For instance, we let them extract DNA from bananas. </p>
+
                                        <p>In the course of our introduction, the children of Yanwu Primary school expressed their great enthusiasm, responded positively to our interaction, and moreover they showed terrific zest for our introduction. In these next simple experiments, the children were thrilled to be involved in one of the experiments.</p>
+
                                        <p>In the end, through our teaching and guidance, most of the children have achieved remarkable results during the experiments. After the event, Yanwu Elementary school students said they learned a lot of useful knowledge, and very happy to do these interesting experiments by themselves within our guidance.</p>
+
                                        <p>Also, the teacher fed back that they think this activity is so meaningful, extremely hoping to hold more such events in the primary school campus.</p>
+
                                        <p class="F3"><img src="https://static.igem.org/mediawiki/2018/8/8e/T--XMU-China--HP-part3-8.jpg"><img src="https://static.igem.org/mediawiki/2018/7/73/T--XMU-China--HP-part3-9.jpg"></p>
+
                                    </div>
+
                                </div>
+
                            </div>
+
                            <div class="expstep_name">Idea and Wisdom</div>
+
                            <div class="panel">
+
                                <div class="panel-collapse collapse in" role="tabpanel">
+
                                    <div class="panel-body no_top">
+
                                         <p class="com"> No one can make great progress without advice and golden ideas from their excellent partners. During last six months, we participated in some iGEM conferences or even worked as the innovative online meeting organizers. Hopefully these events contributed greatly to all of us.</p>
+
                                    </div>
+
                                </div>
+
                            </div>
+
                            <div class="panel">
+
                                <div class="panel-heading" role="tab" id="heading17_1">
+
                                    <h4 class="panel-title">
+
                                <a class="collapsed" role="button" data-toggle="collapse" data-parent="#accordion" href="#collapse17_1" aria-expanded="false" aria-controls="collapse17_1">
+
                                    The CCiC
+
                                </a>
+
                            </h4>
+
                                </div>
+
                                <div id="collapse17_1" class="panel-collapse collapse" role="tabpanel">
+
                                    <div class="panel-body">
+
                                        <p> The 5th CCiC, which full name is the Conference of China iGEMer Community Meetup, was held at ShanhaiTech University on the subject of “Among us, past, present and future meeting” from August 27th to 31th. Dozens of teams from all over the China as well as the Executive Vice President and Chief Operating Officer if the iGEM Foundation, Meagan Lizarazo took part in. During this conference, we fortunately got the chance to have deep communication with many iGEM teams including iGEM_BIT(Beijing Institute of Technology University), iGEM Tianjin (Tianjin Unniversity) and LZU_China (Lanzhou University), and here we really appreciated their advices on our project about the competitive experiments, Kai ABC systems and the OMVs systems. Luckily, we won the best presentation award. What’s more, we were greatly benefited from Meagan’s lecture pointing out the importance of “After iGEM”. This strengthened our determination to contact the old members of XMU-China and luckily we got precious experiences and further understanding about this competition.
+
 
                                         </p>
 
                                         </p>
                                        <p class="F3"><img src="https://static.igem.org/mediawiki/2018/f/f6/T--XMU-China--hp-part4-1.jpg"><img src="https://static.igem.org/mediawiki/2018/e/e5/T--XMU-China--hp-part4-2.jpg"></p>
+
                                    </p>
                                            <p class="F25"><img src="https://static.igem.org/mediawiki/2018/e/e5/T--XMU-China--hp-part4-3.jpg"></p>
+
                                     <h1>References</h1>
                                     </div>
+
                                     <p class="reference">[1] Yanling Song, Zhi Zhu, Yuan An, Weiting Zhang, Huimin Zhang, Dan Liu, Chundong Yu, Wei Duan, Chaoyong James Yang, Selection of DNA Aptamers against Epithelial Cell Adhesion Molecule for Cancer Cell Imaging and Circulating Tumor Cell Capture, <i>Anal Chem</i>, <strong>2013</strong>, 85, 4141-4149. <br>
                                </div>
+
                                         [2] DS Smith, SA Eremin, Fluorescence polarization immunoassays and related methods for simple, high-throughput screening of small molecules, <i>Analytical and bioanalytical chemistry</i>, <strong>2008</strong>, 391 (5) :1499. <br>
                            </div>
+
                                         [3] Chen JS, Ma E, Harrington LB, Da Costa M, Tian X, Palefsky JM, Doudna JA, CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity, <i>Science</i>, <strong>2018</strong>, 360 (6387) : seaar6245
                            <div class="panel">
+
                                     </p>
                                <div class="panel-heading" role="tab" id="heading18">
+
            </section>
                                     <h4 class="panel-title">
+
            <section id="OMVs" class="js-scroll-step">
                                <a class="collapsed" role="button" data-toggle="collapse" data-parent="#accordion" href="#collapse18" aria-expanded="false" aria-controls="collapse18">
+
                <div class="headline">
                                The 6<sup>th</sup> Asia-Pacific iGEM Conference
+
                     The result of OMVs
                                </a>
+
                            </h4>
+
                                </div>
+
                                <div id="collapse18" class="panel-collapse collapse" role="tabpanel">
+
                                    <div class="panel-body">
+
                                         <p>
+
                                            From July 30<sup>th</sup> to August 3<sup>rd</sup>, 2018, we participated in the 6th Asia-Pacific iGEM Conference hosted by National Chung Hsing University, Taichung. There was a total of 22 teams and 140 participants from Taiwan, China, and Japan, warming up for the final Jamboree in Boston at the end of October.
+
                                        </p>
+
                                         <p>The conference invited wonderful speakers from the field of Synthetic Biology and Ambassador of the iGEM HQ to give a talk at the Opening Ceremony. Among them, Prof. Kenji Tsuge from Kobe University explained the emerging synthetic biology technology that can link quantities of large fragments of genes and perform these genes; Dr. Zhang Jui-Jen, an associate researcher at China Medical University Hospital, shared his experience in using synthetic biology entrepreneurship; iGEM Asian Ambassador Chen Hong explained some new systems and shared experience on behalf of iGEM. We gained tons of new ideas from these lectures, which had great influences on our next work.</p>
+
                                        <p>In the five-day conference, we also had a 20-minute English presentation and a poster exhibition. It was the first time to present our project frankly to iGEMers from Asia, and a good opportunity to practice for the final Jamboree. At the end of the exhibition, Prof. Wenming Yang from the field of molecular biology at National Chung Hsing University gave a comment on our presentation. Through the conference, we also made suggestions to other Asian teams, longing for more cooperation opportunities.</p>
+
                                        <p>This conference has provided us tremendous new ideas to improve our project and final presentation.</p>
+
                                        <p class="F3"><img src="https://static.igem.org/mediawiki/2018/6/62/T--XMU-China--hp-part4-4.jpg"></p>
+
                                     </div>
+
                                </div>
+
                            </div>
+
                            <div class="panel">
+
                                <div class="panel-heading" role="tab" id="heading19">
+
                                    <h4 class="panel-title">
+
                                <a class="collapsed" role="button" data-toggle="collapse" data-parent="#accordion" href="#collapse19" aria-expanded="false" aria-controls="collapse19">
+
                                    Collaborations
+
                            </h4>
+
                                </div>
+
                                <div id="collapse19" class="panel-collapse collapse" role="tabpanel">
+
                                    <div class="panel-body">
+
                                        <p> Collaborations with other teams are indispensable links in the iGEM competition. You can <a class="click_here" href="https://2018.igem.org/Team:XMU-China/Collaborations">click here</a> to see what collaborations that we have done this year, and what achievements we have got.
+
                                        </p>
+
                                    </div>
+
                                </div>
+
                            </div>
+
                        </div>
+
                     </div>
+
 
                 </div>
 
                 </div>
 +
                <h1>The growth curve of IPTG-induced and Arabinose-induced E. coli BL21</h1>
 +
                <p>To ensure when we should add the inducer, we measured the growth curve of BBa_K2623026 (IPTG-induced) and BBa_K2623027 (Arabinose-induced). According to figure 1a, we found that after incubation for 5 h, the OD600 of BBa_K2623026 (IPTG-induced) reached to about 0.6, which is suitable for adding IPTG to a final concentration at 0.5 mM. Figure 1b shows that after incubation for 5 h, the OD600 of BBa_K2623027 (Arabinose-induced) reached to about 0.6, which is suitable for adding Arabinose to a 0.2% final concentration.
 +
                </p>
 +
                <p class="F2">
 +
                    <img src="https://static.igem.org/mediawiki/2018/5/53/T--XMU-China--results2-1.png">
 +
                    <p class="Figure_word"><strong>Figure 1.</strong> Growth curve of (a) IPTG-induced and (b) Arabinose-induced E. coli BL21.</p>
 +
                </p>
 +
                <h1>OmpA-ST could be transported to OMVs</h1>
 +
                <p>OmpA-SpyTag (OmpA-ST) is transported to bacterial outer membrane and therefore OMVs. However, E. coli could produce natural OmpA and then transport it to its outer membrane and OMVs as well. It’s necessary to know how much OmpA-ST is transported to OMVs or what the ratio of the OMVs-ST is in total OMVs. To evaluate the efficiency of its transport to outer membrane and OMVs, we fused wtGFP and our OmpA-ST (BBa_K2623022 and BBa_K2623024) together in order to construct OmpA-ST-GFP (BBa_K2623021 and BBa_K2623023) (Figure 2).</p>
 +
                <p class="F2">
 +
                    <img src="https://static.igem.org/mediawiki/2018/b/b8/T--XMU-China--results2-2.png">
 +
                    <p class="Figure_word"><strong>Figure 2.</strong> The spectrogram of wtGFP <sup>[1]</sup>. </p>
 +
                </p>
 +
                <p>We cultured bacteria transfected with these four parts respectively in 10 mL OMVs-free LB broth culture and extracted the OMVs according to our protocols, in which two forms of non-GFP OMVs were set as negative controls. Transmission electron microscopy (TEM) pictures identified what we extracted were exactly OMVs with membrane structure and 100-nm diameter (Figure 3). </p>
 +
                <p class="F2">
 +
                    <img src="https://static.igem.org/mediawiki/2018/0/06/T--XMU-China--results2-3.png">
 +
                    <p class="Figure_word"><strong>Figure 3.</strong> TEM figures identify our OMVs. </p>
 +
                </p>
 +
                <p>
 +
                    Building upon Yan’s lab-built high-sensitivity flow cytometer <sup>[2] [3]</sup>, we successfully detected the OMVs labelled with GFP and evaluated the efficiency of its transport to OMVs (Figure 4). Herein, we'd like to extend our heartfelt thanks toward Yan's lab due to the very kind and selfless help during the experiment.
 +
                </p>
 +
                <p class="F2">
 +
                    <img src="https://static.igem.org/mediawiki/2018/f/f4/T--XMU-China--results2-4.png">
 +
                    <p class="Figure_word">
 +
                        <strong>Figure 4.</strong> HSFCM analysis of OmpA-ST-GFP inside OMVs.
 +
                    </p>
 +
                </p>
 +
                <p>Figure 4 are bivariate dot-plots of GFP green fluorescence versus side scattering (SSC) for our OMVs isolates. E. coli transfected with BBa_K2623021 (Figure 4a) could secret more OMVs labeled with GFP than E. coli transfected with BBa_K2623022 (Figure 4b). Similarly, E. coli transfected with BBa_K2623023 (Figure 4c) would secret more OMVs labeled with GFP than E. coli transfected with BBa_K2623024 (Figure 4d). Moreover, we could see E. coli transfected with BBa_K2623021 (Figure 4a) would transport OmpA-ST to OMVs more efficiently than E. coli transfected with BBa_K2623023 (Figure 4c). The remarkable difference of GFP-OMVs ratio between these two parts might account for the different inserted site of ST. SpyTag (ST) in BBa_K2623021 (Figure 4a) is inserted to N-termini of OmpA, while ST in BBa_K2623023 (Figure 4c) is inserted to C-termini of OmpA. Our HSFCM data shows that BBa_K2623021 is more efficient to transport ST-OmpA-GFP to OMVs and might be a good candidate for the following study.</p>
 +
                <h1>References</h1>
 +
                <p class="reference">
 +
                    [1] https://www.semrock.com/ <br>
 +
                    [2] Zhu S, Ma L, Wang S, et al. Light-Scattering Detection below the Level of Single Fluorescent Molecules for High-Resolution Characterization of Functional Nanoparticles. <i>Acs Nano</i>, <strong>2014</strong>, 8(10):10998-11006. <br>
 +
                    [3] Tian Y, Ma L, Gong M, et al. Protein Profiling and Sizing of Extracellular Vesicles from Colorectal Cancer Patients via Flow Cytometry[J]. <i>Acs Nano</i>, <strong>2018</strong>, 12(1).
 +
                </p>
 +
                <h1>Demonstrate the OmpA-ST inside E. coli BL21 and OMVs</h1>
 +
                <p>As our HSFCM data show, OmpA-ST-GFP (BBa_K2623021 and BBa_K2623023) transported to OMVs could be detected. In our total circuit, we would use non-GFP part (BBa_K2623022 and BBa_K2623024) to establish SpyTag/SpyCatcher (ST/SC) conjugation. For this purpose, we'd like to demonstrate the OmpA-ST (BBa_K2623022 and BBa_K2623024) inside both E. coli BL21 and OMVs, as well as SDS-PAGE used (Figure 5).</p>
 +
                <p class="F25">
 +
                    <img src="https://static.igem.org/mediawiki/2018/a/ad/T--XMU-China--results2-5.png">
 +
                    <p class="Figure_word">
 +
                        <strong>Figure 5.</strong> Lane 1: E. coli BL21 transfected with BBa_K2623022. <br>Lane 2: OMVs secreted by E. coli BL21 transfected with BBa_K2623022. <br>Lane 3: E. coli BL21 transfected with BBa_K2623024. <br>Lane 4: OMVs secreted by E. coli BL21 transfected with BBa_K2623024.
 +
                    </p>
 +
                </p>
 +
                <p>As our SDS-PAGE figure shows, ideal band at about 50 kDa are shown in E. coli BL21 transfected with BBa_K2623022 and BBa_K2623024, respectively. However, we could see neither bands nor traces in lane 2 and lane 4 loading with OMVs samples. We suppose that our sample loadings are not enough for the LOD (limit of detection) of SDS-PAGE followed by Coomassie blue staining. Because of limited time, we couldn’t repeat this experiment. Whatever, our HSFCM data have shown that OmpA-ST could be encapsulated into OMVs.</p>
 +
                <h1>Demonstrate the SC-L7Ae inside E. coli BL21</h1>
 +
                <p>Similarly, in our total circuit, we used non-RFP part (BBa_K2623026) to fulfill L7Ae-C/Dbox linkage. It's demonstrated that the SpyCatcher (SC)-L7Ae could be expressed inside E. coli BL21 firstly. Under the induction of IPTG at 0.5 mM, we could detect the expression of SC-L7Ae (Figure 6).</p>
 +
                <p class="F25">
 +
                    <img src="https://static.igem.org/mediawiki/2018/9/99/T--XMU-China--results2-6.png">
 +
                    <p class="Figure_word">
 +
                        <strong>Figure 6.</strong> SDS-PAGE figure of the SC-L7Ae. <br>Lane 1: induced-BL21. <br>Lane 2: uninduced-BL21. The red arrow points to the band of the SC-L7Ae.
 +
                    </p>
 +
                </p>
 +
                <p>Though no IPTG was added into E. coli BL21 as negative control (lane 2), we could still see our band at about 70.4 kDa indicated for SC-L7Ae. However, SDS-PAGE is not an ideal approach for identify our targeted protein. In our future plans, we would use anti-SC mAb to immunoblot our SC-LA7e. (See our future plans).</p>
 +
                <p>Demonstrate the ST/SC conjugation inside OMVs</p>
 +
                <p>Though we have revealed the OmpA-ST inside OMVs, we are inclined to figure out the ST/SC bioconjugation inside OMVs. Hence, we fused mRFP1 to SC-L7Ae (BBa_K2623026) to build SC-L7Ae-RFP (BBa_K2623025) (Figure 7). We linked our two non-GFP OmpA-ST parts (BBa_K2623022 and BBa_K2623024) with BBa_K2623025 and BBa_K2623026 to form four new parts:</p>
 +
                <p class="reference">1) BBa_K2623022 & BBa_K2623025: BBa_K2623028 (RFP form) <br>
 +
                    2) BBa_K2623022 & BBa_K2623026: BBa_K2623029 <br>
 +
                    3) BBa_K2623024 & BBa_K2623025: BBa_K2623030 (RFP form) <br>
 +
                    4) BBa_K2623024 & BBa_K2623026: BBa_K2623031
 +
                </p>
 +
                <p>Under the induction of IPTG, L7Ae could be expressed with SpyCatcher and RFP modification and then be encapsulated into OMVs through ST/SC conjugation. OMVs labeled with RFP will be detected through HSFCM.</p>
 +
                <p class="F2">
 +
                    <img src="https://static.igem.org/mediawiki/2018/7/73/T--XMU-China--results2-7.png">
 +
                    <p class="Figure_word">
 +
                        <strong>Figure 7.</strong> a) Genetic circuit of SC-L7Ae-RFP <sup>[1]</sup>. <br>b) The spectrogram of mRFP1.
 +
                    </p>
 +
                </p>
 +
                <p class="F2">
 +
                    <img src="https://static.igem.org/mediawiki/2018/a/a1/T--XMU-China--results2-8.png">
 +
                    <p class="Figure_word">
 +
                        <strong>Figure 8.</strong> HSFCM analysis of ST/SC bioconjugation inside OMVs.
 +
                    </p>
 +
                </p>
 +
                <p>Figure 8 contains bivariate dot-plots of RFP red fluorescence versus side scattering (SSC) for our OMVs isolates. E. coli BL21 transfected with BBa_K2623028, BBa_K2623029, BBa_K2623030, BBa_K2623031 were incubated with OMVs-free LB culture for about 5 hours to get a 0.6-0.8 OD600 respectively, in which BBa_K2623029 and BBa_K2623031 were set as negative controls. Then IPTG was added to a final concentration at 0.5 mM and nurture the bacteria overnight. OMVs were isolated according to our protocols and then analyzed by HSFCM. It’s interesting to note that E. coli transfected with BBa_K2623030 (Figure 3c) could secret more RFP-OMVs than BBa_K2623028 (Figure 3a), indicating that ST/SC conjugation inside OMVs is more efficient with ST at the C-termini of OmpA. This result is inconsistent with the result shown in Figure 4, in which ST at the N-termini of OmpA (BBa_K2623028) has a higher efficiency to be encapsulated inside OMVs. We propose that GFP inserted to OmpA might interfere the transport of OmpA-ST (BBa_K2623021 and BBa_K2623023) to OMVs. </p>
 +
                <h1>References:</h1>
 +
                <p class="reference">[1] https://www.semrock.com/</p>
 +
                <h1>Demonstrate the L7Ae-C/Dbox conjugation inside OMVs</h1>
 +
                <p>Our OMVs module is designed for siRNA delivery and then for cancer treatment. To demonstrate the conjugation of the L7Ae-C/Dbox inside OMVs, we linked ST/SC part with the box part (BBa_K2623027, see Figure 9) to form our total circuit (BBa_K2623032).</p>
 +
                <p class="F2">
 +
                    <img src="https://static.igem.org/mediawiki/2018/d/db/T--XMU-China--OMVs26.png">
 +
                    <p class="Figure_word">
 +
                        <strong>Figure 9.</strong> Genetic circuit of the Box part (BBa_K2623027).
 +
                    </p>
 +
                </p>
 +
                <p>The box part can code siRNA target for Kras in human pancreatic ductal adenocarcinoma (PDAC) with a C/Dbox RNA structure to bind with L7Ae. </p>
 +
                <p>Under the induction of arabinose at a 0.2% final concentration, we isolated the OMVs according to our protocols and then stained the OMVs isolates with SYTOTM RNASelectTM at 10 M (Figure 10). The stained isolates were analyzed by HSFCM (Figure 11). </p>
 +
                <p class="F2">
 +
                    <img src="https://static.igem.org/mediawiki/2018/b/bf/T--XMU-China--results2-10.png">
 +
                    <p class="Figure_word">
 +
                        <strong>Figure 10.</strong> a) Schematic illustration of our total circuit. <br>b) The spectrogram of SYTOTM RNASelect<sup>TM</sup> <sup>[1]</sup>.
 +
                    </p>
 +
                </p>
 +
                <p class="F2">
 +
                    <img src="https://static.igem.org/mediawiki/2018/9/9b/T--XMU-China--results2-11.png">
 +
                    <p class="Figure_word">
 +
                        <strong>Figure 11.</strong> HSFCM analysis of OMVs stained with SYTOTM RNASelectTM..
 +
                    </p>
 +
                </p>
 +
                <p>Figure 11 are bivariate dot-plots of green fluorescence versus side scattering (SSC) for our OMVs isolates. E. coli BL21 transfected with BBa_K2623029 and BBa_K2623032 respectively were cultured in 100 mL OMVs-free LB culture for about 5 hours to get a OD600 at 0.6-0.8, in which BBa_K2623029 was set as negative control. Then Arabinose was added to a final concentration at 0.2% and after incubation for another 2 hours, IPTG was added to a final concentration at 0.5 mM and then nurtured the bacteria overnight. OMVs were isolated according to our protocols and stained with SYTOTM RNASelectTM. The stain OMVs were analyzed by HSFCM. As we expected, OMVs isolated from BBa_K2623032 could secret more OMVs containing with RNA stained positively by SYTOTM RNASelectTM (Figure 11b) than BBa_K2623029, indicating that our L7Ae and C/Dbox could fulfill their function. It’s a pity that we didn’t have cell culture experiment to test our siOMVs to silence Kras in human pancreatic ductal adenocarcinoma (PDAC). In our future plans, we’ll finish our cell experiment and demonstrate the function of our siOMVs.</p>
 +
                <h1>References</h1>
 +
                <p class="reference">[1] https://www.semrock.com/</p>
 +
                <h1>Future Plan</h1>
 +
                <p>It is not practical to transfer our ideas to a fully-completed project or even a portable device just after an enriched summer. We should learn more for the sake of improving our project, making it suitable for feasible usage. Therefore, we list our future plans to develop our projects.</p>
 +
                <p><strong>Design-1</strong>. Though we have characterized OmpA-ST through SDS-PAGE, in many cases SDS-PAGE is not an optimal method to characterize specific protein in complex samples, like bacterial lysates. For further characterizing our OmpA-ST, we would be inclined to find monoclonal antibody (mAb) specific for SpyTag and Western Blot analysis alike. Exploiting with anti-SpyTag mAb, we supposed that the band at about 50 kDa would be stained positively.</p>
 +
                <p><strong>Design-2</strong>. Similar to Design-1, we would also use monoclonal antibody (mAb) specific for L7Ae and SC to validate our L7Ae-SC. </p>
 +
                <p><strong>Design-3</strong>. For our siRNA-C/Dbox, due to poor experimental instrument, we could only characterize the promotion of RNA level inside our engineering bacteria. The problem is that we could not ensure the presence of our siRNA target for KrasG12D. To characterize this part better, we'd like to use qPCR, FISH (fluorescence in situ hybridization) or low-throughput miRNA target identification method<sup>[1]</sup> to demonstrate our siRNA could target KrasG12D. Through the incubation of siOMVs (OMVs containing siRNA) and human pancreatic ductal adenocarcinoma (PDAC) cell line PANC-1, the silence effect of the siOMVs could be told.</p>
 +
                <p><strong>Design-4</strong>. As mentioned above, our chassis is bacterium. Some researchers have demonstrated not only bacteria but also their OMVs could be pathogenetic. Though some governments have approved the usage of OMVs vaccines, the side effects of the OMVs are still ambiguous. Extracellular vesicles (EVs), originated from eukaryocytes, which are often referred to exosomes and mircovesicles, are better choices for nucleic acid delivery for its biocompatibility and homology. We could conjugate L7Ae to the C-terminus of tetraspanin CD63 and insert a C/Dbox into the 3′-untranslated region (3′-UTR) of the gene coding for siRNA[2].</p>
 +
                <h1>References</h1>
 +
                <p class="reference">[1] Michael J V, Jgt W, Mao G F, et al. Platelet microparticles infiltrating solid tumors transfer miRNAs that suppress tumor growth[J]. <i>Blood</i>, <strong>2017</strong>, 130(5): blood-2016-11-751099. <br>
 +
                    [2] Kojima R, Bojar D, Rizzi G, et al. Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for Parkinson’s disease treatment[J]. <i>Nature Communications</i>, <strong>2018</strong>, 9(1):1305.
 +
                </p>
 +
               
 +
 
             </section>
 
             </section>
             <section id="Competition_experiment" class="js-scroll-step">
+
             <section id="Supporting" class="js-scroll-step">
                 <div class="container">
+
                 <div class="headline">The result of Supporting</div>
                    <div class="row">
+
                <h1>Verify the expression of SAHS protein</h1>
                        <div class="col-md-offset-3 col-md-6">
+
 
                            <div class="exp_name">INTEGRATED HP</div>
+
                <p>Firstly, we used the <a href="http://parts.igem.org/Part:BBa_E1010">BBa_E1010</a> (mRFP) as our report gene to make sure the circuit for expressing the SAHS protein was constructed precisely. But we did not observe the distinct color on the plate as it was so weak unless the E.coli was cultured in a tube and centrifuged. So we had a new test by using the <a href="http://parts.igem.org/Part:BBa_K592009">BBa_K592009</a>(blue chromo protein)as our report gene and got a distinct color on the plate.
                        </div>
+
                </p>
                        <div id="accordion">
+
                <p class="F2">
                            <div class="expstep_name"></div>
+
                    <img src="https://static.igem.org/mediawiki/2018/2/25/T--XMU-China--results3-1.png">
                            <div class="panel">
+
                    <p class="Figure_word">
                                <div id="collapse11-1" class="panel-collapse collapse in" role="tabpanel">
+
                        <strong>Figure 1.</strong> These are the pictures our fluorescently characterized plate and bacterial pellets. The report gene on the left is BBa_K592009, and the one on the right is E1010. Some colonies on the left are blue, which are the DH5α that we successfully transferred to the designed genetic loop. The leftmost EP tube in the right photo is the control, and the other two EP tubes contain DH5α which we had successfully transferred to the designed genetic loop.
                                    <div class="panel-body no_top">
+
                    </p>
                                        <p class="com">This year, Team XMU-China is devoted to combine WET LAB, DRY LAB and Human Practices to form an organic integration, while the Human Practices function as a significant theme. As Peter Carr said, "Human Practices is the study of how your work affects the world, and how the world affects your work." Based on this saying, our team will show the inspiration of our project, the ideas of how to design Human Practice activities and how the activities influence our project in return. What we can feedback to the society is also the point we'll show below.
+
                </p>
                                            <p class="F2"><img src="https://static.igem.org/mediawiki/2018/e/e9/T--XMU-China--gold1.png"></p>
+
                <p>And then, we transformed the plasmid to the E.coli-BL21, which is always used to express proteins with high efficiency to verify the SAHS protein was produced successfully with a small scale. Besides, whether the SAHS protein with a signal peptide could be secreted was determined by SDS-PAGE.</p>
                                           
+
                <p class="F2">
                                    </div>
+
                    <img src="https://static.igem.org/mediawiki/2018/0/02/T--XMU-China--measurement-kai1017-4.png">
                                </div>
+
                    <p class="Figure_word">
                            </div>
+
                        <strong>Figure 2.</strong> The marker is on the lest, followed by our control group (the BL21 with the empty plasmid), and the third well is the concentrated supernatant.
                            <div class="panel">
+
                    </p>
                                <div class="panel-heading" role="tab" id="heading114-2-1">
+
                </p>
                                    <h4 class="panel-title">
+
                <p>
                                <a class="collapsed" role="button" data-toggle="collapse" data-parent="#accordion" href="#collapse114-2-1" aria-expanded="false" aria-controls="collapse114-2-1">
+
                    As shown in the image above, we also explored the appropriate temperature for SAHS protein expression. As we expected, protein expression was be more efficient at 30 °C. However, we did not find the SAHS protein band in the supernatant even when it was concentrated by ultrafiltration. So we speculated that cell wall obstructed the secretion of protein on the basis of 2016 Peking University’s working. See more information on <a href="https://2016.igem.org/Team:Peking/Secretion">the page.</a>
                                    During the Brainstorm stage:
+
                </p>
                                </a>
+
                <p>Therefore, we have to design a new protein purification program. To get enough protein produces for the following experiment, the gene was cloned into the vector pET-28a with high expression lever combined with E.coli-BL21. Besides, Two HIS-TAGs on the end of N-and C-terminal was produced and allow SAHS protein to bind with Nickel column (like Ni-NTA) for purification. Meanwhile, we purified the sample with heat water bath considering the characterization of heat stability by following the reference.</p>
                            </h4>
+
                <p class="F2">
                                </div>
+
                    <img src="https://static.igem.org/mediawiki/2018/4/47/T--XMU-China--results3-3.png">
                                <div id="collapse114-2-1" class="panel-collapse collapse" role="tabpanel">
+
                    <p class="Figure_word">
                                    <div class="panel-body">
+
                        <strong>Figure 3.</strong> The picture on the left is a series of temperature gradient processed protein samples. The number represents the temperature (°C). And the picture on the right is the gel map of our final purified high purity SAHS protein.
                                        <P>Before having the discussion with Prof. Zhi Zhu, we read related literatures <sup>[1]</sup>, and made the initial determination of using the aptamer sequence, SYL3C, which was referred to in literatures. In the beginning, we came up with three methods (Figure 1) to realize the ABCD system. However, we had no idea about the concrete operations. That was just the reason why we had the meeting with Prof. Zhi Zhu. After listening to the three methods proposed by us, Prof. Zhi Zhu offered personal opinions about them. After taking time restriction and operation feasibility into considerations, we ultimately chose the “competing method” (Figure 1.B) to realize our system. Not only did Prof. Zhi Zhu give us beneficial recommendations, but gave us specific guidance about how to apply the “competing method”. For example, he proposed that we had better use streptavidin magnetic beads as the carriers, and attached biotin on the end position of SYL3C aptamer sequence. </P>
+
                    </p>
                                        <p class="F3"><img src="https://static.igem.org/mediawiki/2018/7/79/T--XMU-China--gold2.png">
+
                </p>
                                            <p class="Figure_word">Figure 1. Initiative methods to enable ABCD system. A) Method A. B) Method B. C) Method C.</p>
+
                <p>So, we designed a set of temperature gradients from 70°C to 90°C, to explore the appropriate condition. What’s more, we chose the 85℃ for 15mins finally for large scale purification. But given that there were many other protein bands, we combined heating with Nickel column for producing high quality protein. Finally, we tested two patterns, heating-Ni-NTA and Ni-NTA-heating, and found that the later one is better.</p>
                                        </p>
+
                <p>After that, we obtained a protein sample with high concentration and purity by using this protein purification method(Figure 3).</p>
                                        <p>Therefore, the close combination of streptavidin and biotin could be exploited to fix the aptamer. She also reminded that in order to keep the reactions of competition as far away as possible from the surface of the carriers, TEG could be inserted between biotin and the aptamer sequence. In that case, TEG could serve as a spacer to reduce the effects of reactions on the surface. Suggestions like these, which were offered by our professor were quite a lot. These suggestions enormously facilitated the design of our experiment. On top of that, professor Zhu also listened to our ideas about the the designed model of thermodynamics (See more details in our <a href="https://2018.igem.org/Team:XMU- China/Model#Thermodynamic_model">Modeling page</a>). From her perspective, our ideas were quite acceptable. What more, she pointed out that we could try the “Complementary Trand”, which uses 9nt or even more basic groups, to realize the mutual complement. This suggestion also benefited our experiment and modeling to some extent. Another case worth mentioning is that, when we were encountered with difficulties when using flow cytometry to verify the combination of SYL3C and EpCAM, it was professor Zhu who helped us out of the woods. She suggested us to use another method, fluorescence polarization, to verify the combination of those two molecules <sup>[2]</sup>. Her advice turned out to be wise and feasible. Finally, we used that method and successfully verified the combination. (See more details in our <a href="https://2018.igem.org/Team:XMU-China/Results#ABCDsystem">Results page</a>).</p>
+
                <h1>Verify the role of SAHS protein in preserving biological activity</h1>
                                    </div>
+
                <p>In order to verify the preservation effect of SAHS protein, we used the lyophilization method. First, we tested the concentration of purified SAHS protein, which ranged from 0.3 g/L to 0.6 g/L. Then, we concentrated the purified protein to control the protein concentration to about 1 g/L.</p>
                                </div>
+
                <p>We selected Taq enzyme as the protein preserved in our experiment, using SAHS protein as protective agent, and set a series of concentration gradients: 1g/L, 0.5g/L, 0.1g/L, 0.01g/L and 0g/L, then stored with lyophilization. In order to verify the preservation effect of SAHS protein, we resuscited the lyophilized sample and performed PCR experiments to verify the activity of Taq enzyme. The activity of Taq enzyme can be reflected by the product of PCR.</p>
                            </div>
+
                <p class="F0">
                            <div class="panel">
+
                    <img src="https://static.igem.org/mediawiki/2018/0/01/T--XMU-China--results3-4.png">
                                <div class="panel-heading" role="tab" id="heading114-2-2">
+
                    <p class="Figure_word">
                                    <h4 class="panel-title">
+
                        <strong>Figure 4.</strong> PCR results of Taq enzymes preserved at different SAHS protein concentrations.
                                <a class="collapsed" role="button" data-toggle="collapse" data-parent="#accordion" href="#collapse114-2-2" aria-expanded="false" aria-controls="collapse114-2-2">
+
                    </p>
                                    During the experimental stage:
+
                </p>
                                </a>
+
                <p>We selected different PCR systems for verification. We found that some short fragments were easy to succeed, but there was no obvious gradient. However, when we replaced them with some other fragments that are difficult to succeed or very long, there would show a very obvious gradient. We think it must be that a shorter fragments were too easy to succeed, and made the base too large. The two fragments above are pET-28a, which had a relatively obvious gradient and also had a good repeatability.</p>
                            </h4>
+
                <p class="F2">
                                </div>
+
                    <img src="https://static.igem.org/mediawiki/2018/d/da/T--XMU-China--results3-5.png">
                                <div id="collapse114-2-2" class="panel-collapse collapse" role="tabpanel">
+
                    <p class="Figure_word">
                                    <div class="panel-body">
+
                        <strong>Figure 5.</strong> The result of the comparison of PBS and ultra-pure water. Blank is the group that the Taq enzyme has not been lyophilized and without SAHS protein.
                                        <p><h1>After Fang’s sketch completed</h1>
+
                    </p>
                                        </p>
+
                </p>
                                        <p>In order to seek confirmation about the prospect of our project and Fang on cancer detection, we consulted this on Prof. Xue. We exchanged and discussed with Prof. Xue about the design of aptamer-based cell free detection system (ABCD System) and the design of microfluidic chip drives by centrifugal force. On the one hand, Prof. Xue fully affirmed the innovation and feasibility of this project. On the other hand, Prof. Xue though it that if we could find a more specific biomarker from one cancer like liver cancer, which would strengthen the academic persuasion of our project. We communicated with Prof. Xue about the next clinical trial plan of the detection hardware, and reached a preliminary cooperation agreement. If possible, we could take the instrument to the lab in hospital, and use the patient's blood sample to verify the performance of the instrument, such as stability and sensitivity.</p>
+
                <p>In addition, we also made a comparison between  PBS and ultra-pure water. We found that regardless of the presence of TDP, the lyophilized system added with PBS could not make the correct band. On the contrary, there was only one large band which was much larger than 8000bp. We think it may be a PCR mismatch. Considering that PBS contained a large amount of salt, it was likely that these salt ions affected the binding of Taq enzyme to Mg2+.</p>
                                        <p><h1>After the first generation product of Fang completed</h1>
+
                <p class="F0">
                                        </p>
+
                    <img src="https://static.igem.org/mediawiki/2018/a/ac/T--XMU-China--results3-6.png">
                                        <p>In order to prove the feasibility of our project, we consulted the Chief Physician Weiwei Tang. During the talk, Dr. Tang appreciated it that our ideas are of social significance. What’s more, Dr. Tang also told us most of those frequently-used and classical clinical detection methods, like ELISA, CLIA and so on are time-consuming, expensive and complex, compared with Fang. <br>
+
                    <p class="Figure_word">
                                            As for Fang, Dr. Tang agreed with our proposals that we are going to make Fang widely used among basic medical institutions, especially in remote and poverty-stricken areas because of its convenient and practicability. But it’s worth noting that today there is an authoritative method for disease-diagnose, that is pathological diagnosis. So our detection method would just serve as a kind of screening tool rather than diagnosis method, according to Tang’s suggestion. We also should pay attention to the testing sensitivity of our project if it could meet national standards or even better.
+
                        <strong>Figure 6.</strong> The ruselt of the success rate of PCR with Taq enzymes preserved at different SAHS protein concentrations.
                                        </p>
+
                    </p>
                                        <h1>After the first generation of software tool completed</h1>
+
                </p>
                                        <p>In order to improve our software part, we had an enjoyed talk with Mr. Wu about the communication mode between team’s hardware and software, especially practicability of software design. Mr. Wu fully affirmed its innovation and praised team’s consciousness of social responsibility. Also he gave us his own opinions on our project. As for APP part, he gave some professional advices and technical guidance, like how to accelerate our convolution neural network recognition speed with collected increasing number of images cases, and how to link block them up between chain technology public health service database to serve the public better. It’s key point for us to develop and improve our software that we want to combine specific functions with advanced tool like AI. In addition, as an outstanding entrepreneur, Mr. Wu gave us a lot of advice, from his early experience, on product promotion and profit model.
+
                <p>Then, we tried some shorter fragments for PCR, and interfered with the PCR system by reducing time extension and reducing the concentration of the template in order to explore the success rate of PCR. As the figure showed, when the concentration of SAHS protein was 0.5g/L, the success rate of PCR was the highest. We suspected that excessive concentration of SAHS protein might affect the normal function of the Taq enzyme and might affect the binding of the enzyme to the substrate. This reminded us of the results of TUDelft in 2017. They also got the result of that 0.5g/L was better than 1g/L in some cases. Eventually, they took a concentration of 1g/L to preserve Cas13a. They discovered that while CAHS 94205 preserved Cas13a’s RNase-like activity after drying, CAHS 94205 could not preserve its specificity. This is exactly the same as ours when the concentration is 1g/L. Therefore, we believe that it is possible that they just did not find the most suitable storage concentration, and if the concentration is properly reduced, the results may be much better.</p>
                                        </p>
+
                <h1>Conclusion</h1>
                                    </div>
+
                <p>According to the experimental results of lyophilization above, we can clearly see the preservation effect of SAHS protein on protein activity. Secondly, when the concentration is too high, SAHS protein may affect the normal function of protein. Therefore, it is necessary to find the most appropriate concentration. The optimal concentration may vary slightly among different proteins, but the preservation of biological activity by SAHS proteins is undoubtable. We believe that SAHS protein is a promising bioactive protective agent for different preservative substances, as long as the appropriate preservation system is set up.</p>
                                </div>
+
                <p>Verify the expression of CAHS protein</p>
                            </div>
+
                <p class="F2">
                            <div class="panel">
+
                    <img src="https://static.igem.org/mediawiki/2018/7/7f/T--XMU-China--results3-7.png">
                                <div class="panel-heading" role="tab" id="heading115-1-1-1">
+
                    <p class="Figure_word">
                                    <h4 class="panel-title">
+
                        <strong>Figure 7.</strong> The circuit of BBa_K2623014
                                <a class="collapsed" role="button" data-toggle="collapse" data-parent="#accordion" href="#collapse115-1-1-1" aria-expanded="false" aria-controls="collapse115-1-1-1">
+
                    </p>
                                    During the characterization stage:
+
                </p>
                                </a>
+
                <p>In the circuit, the Lac I was expressed constantly, and Lac O, lac repressor was bound to Lac O. Following the CAHS gene was our reporter gene mRFP (J04650). When we added IPTG in the bacterial solution, the IPTG bound to repressor and inactivated it. So the CAHS gene and mRFP would start to express.</p>
                            </h4>
+
                <p class="F7">
                                </div>
+
                    <img src="https://static.igem.org/mediawiki/2018/d/dc/T--XMU-China--results3-8.png">
                                <div id="collapse115-1-1-1" class="panel-collapse collapse" role="tabpanel">
+
                    <p class="Figure_word">
                                    <div class="panel-body">
+
                        <strong>Figure 8.</strong> the E.coli-DH5а with BBa_K2623014 and IPTG turns red.(D+ is E.coli-DH5а with BBa_K2623014 and IPTG, D- is E.coli-DH5а with BBa_K2623014 without IPTG, D0 is E.coli-DH5а without BBa_K2623014)
                                        <h1>After the final generation product of Fang</h1>
+
                    </p>
                                        <p>As we imaged, we want to apply our hardware among grass-root medical center in the future. So we visited Health Service Center of Datong Street to learn about the development of tumor markers detection work in primary hospitals from President Zhan. We found that primary hospitals were mostly able to carry out screening on only one kind of basic tumor markers such as alpha fetoprotein (AFP). If people want to carry out more systematic and specific tumor screening, they had to be referred to higher-level hospitals. What’s more, due to the implementation effect of Chinese medical security system and Xiamen's health policy, the screening of tumor markers at the grassroots-level health center could save about 50% of the cost compared with the large hospitals, which is beneficial for people to have cancer detection on regular. It also met our vision about the social role of our hardware. Therefore, to sum up, president Zhan affirmed the future prospects of our instruments, believing it would solve problems such as "difficult access to medical services" in real life, to better provide more convenient medical and health services.</p>
+
                </p>
                                        <h1>Before we design the Business Plan</h1>
+
                <p>We found that the red fluorescent protein expressed very slowly. After we added IPTG in the 4mL bacterial solution, we put the bacterial solution in 25° shaker culture. After 12 hours, we saw the centrifugal precipitation color showed red.</p>
                                        <p>In order to learn about startup and operate a company in medical field, we visited Mr. Su. He shared with us his experience of setting-up a new company, and rendered us prepared for drawing up business plans. <br>
+
                <p>We also did experiment with E.coli-BL21, but the bacteria didn’t turn red.</p>
                                            In the view of Mr. Su, having a sufficient knowledge about not only your company, but your competitors’ on the basis of market analysis was the premise of drawing up a good business plan. Given that starting a new business is tough, Mr. Su believed that our team would encounter five “new” threats in the initial stage, that is, new team, new cooperation partners, new capital, new technologies and new customers. Referring to his personal accumulated experience, Mr. Su further gave us some suggestions targeting on starting a new business: considering that China’s current intellectual property law system was still imperfect, innovative companies, like ours, who were known for their technological advantages must emphasize the patent-protection. What’s more, when our brand was still not so influential compared to those prestigious companies, we should put seeking target customers and broadening sales channels on the front burner, and carefully prevent our technology property right from being infringed. On top of that, he proposed that since our hardware product was based on the "government + grassroots + personal" operation mode, it was necessary to work hard in marketing, with clear targets and strategies.
+
                <p>We cultured the E.coli-BL21 which contained the plasmid of CAHS protein (BBa_K2623014) in the fluid medium. When the value of OD600 reached about 0.6, we took 4ml bacteria solution in the glass test tubes and added 4μL IPTG in the tubes. And then put them in 25° shaker culture for 5hs. Then, we took 1mL bacterial liquid to centrifugalize. We picked the precipitation and added 100μL DDW and 20μL SDS loading buffer. After that, we heated and boiled it for 15 minutes. And then, it was separated by SDS-PAGE and stained with Coomassie brilliant blue for 40 minutes. Ultimately, we decolorized it and observed the results.</p>
                                        </p>
+
                <p>We find the CAHS is surely expressed in the E.coli-BL21 after adding IPTG. Here is the result.</p>
                                        <p class="F3"><img src="https://static.igem.org/mediawiki/2018/8/83/T--XMU-China--Entrepreneurship-9.png"></p>
+
                <p class="F25">
                                    </div>
+
                    <img src="https://static.igem.org/mediawiki/2018/c/c0/T--XMU-China--results3-9.png">
                                </div>
+
                    <p class="Figure_word">
                            </div>
+
                        <strong>Figure 9.</strong> the CAHS protein express in SDS-PAGE. (1, 2, 3 is all with BBa_K2623014. 1 is BL21 with IPTG and pre-heat, 2 is BL21 with IPTG, 3 is BL21 without IPTG, 4 is BL21 without the BBa_K2623014.)
                            <div class="panel">
+
                    </p>
                                <div class="panel-heading" role="tab" id="heading114-2-3">
+
                </p>
                                    <h4 class="panel-title">
+
                <p>The picture of SDS-PAGE shows the CAHS protein is surely expressed in B+ group (the E.coli-BL21 with BBa_K2623014 with IPTG). And CAHS protein isn’t expressed in the B- group (the E.coli-BL21 with BBa_K2623014 without IPTG) and B0 group (the E.coli-BL21 without BBa_K2623014).</p>
                                <a class="collapsed" role="button" data-toggle="collapse" data-parent="#accordion" href="#collapse114-2-3" aria-expanded="false" aria-controls="collapse114-2-3">
+
                <p>We also did experiments with E.coli-DH5а, but the SDS-PAGE showed there was no CAHS protein. Because the E.coli-BL21 is a kind of strain which can knock out proteases while the E.coli-DH5а not. We guess the CAHS protein in E.coli-DH5а is degraded. So we chose the BL21 to verify the function of CAHS.</p>
                                    Public Engagement Level:
+
                <h1>Verify the role of CAHS protein in preserving biological activity</h1>
                                </a>
+
                <p>The SDS-PAGE showed the CAHS protein was really expressed in BL21. We cultured the E.coli-BL21 bacteria which contained the plasmid BBa_K2623014. We picked the E.coli-BL21 bacterial liquid for freeze-drying. First of all, we picked 1mL bacterial liquid to centrifugalize, added 100μL protective agent (LB+5% Sucrose), and put them in -20°refrigerator for 2h. And then, we put them in -80° for one thorough night, and then freeze-dried them (Advantage ES-53).</p>
                            </h4>
+
                <p>After lyophilization, we added 500μL PBS in each centrifuge tube, and put them in 37° shaker culture for 15mins. We also added 500μL DDW in each centrifuge tube. And then, we took 100μL the dilute bacteria liquid, added in 900μL DDW, repeated the step, and carried out gradient dilution to 104, 105, 106. Then, we picked 200μL dilute bacteria liquid, and coated the plate with chloramphenicol.</p>
                                </div>
+
                <p class="F2">
                                <div id="collapse114-2-3" class="panel-collapse collapse" role="tabpanel">
+
                    <img src="https://static.igem.org/mediawiki/2018/3/37/T--XMU-China--results3-10.png">
                                    <div class="panel-body">
+
                    <p class="Figure_word">
                                        <p>
+
                        <strong>Figure 10.</strong> gradient dilution.
                                            Working on synthetic biology in a lab is amazing, but sharing our enthusiasms can be even more wonderful. For the science education, we worked with people from all walks of life including teenagers, citizens, freshmen and XMU students. <br>
+
                    </p>
                                            You can see more details by <a class="click_here" href="https://2018.igem.org/Team:XMU-China/Public_Engagement">click here</a>.</p>
+
                </p>
                                    </div>
+
                <p>The results showed that CAHS protein could improve the preservation effect of freeze-drying bacteria significantly!</p>
                                </div>
+
                <p>The B+ group’s CFU is 100 times higher than the B0 group, 30 times better than the B- group. So we think the CAHS is leaking expression in B- group, which has some of the protection for the bacteria in freeze-drying.</p>
                            </div>
+
                <p>After being irradiated by UV for 1min, the B0 group was nearly fully dead, and the CFU of B- group had been decrease to a very low level, while the B+ group was higher. So we think the CAHS is can provide some of certain protection against UV.</p>
                            <div class="panel">
+
                <p class="F2">
                                <div class="panel-heading" role="tab" id="heading114-2-5">
+
                    <img src="https://static.igem.org/mediawiki/2018/b/b8/T--XMU-China--results3-11.png">
                                    <h4 class="panel-title">
+
                    <p class="Figure_word">
                                <a class="collapsed" role="button" data-toggle="collapse" data-parent="#accordion" href="#collapse114-2-5" aria-expanded="false" aria-controls="collapse114-2-5">
+
                        <strong>Figure 11.</strong> The CFU of BL21. (B0 is E.coli-BL21 without BBa_K2623014, B+ is E.coli-BL21 with BBa_K2623014 and IPTG, B- is E.coli-BL21 with BBa_K2623014, UV means the desiccant bacterial under UV for 1min.)
                                    Laws and Regulations Level:
+
                    </p>
                                </a>
+
                </p>
                            </h4>
+
                <p>This result shows that the CAHS can provide production for bacteria in freeze-drying. And the CAHS can also provide CAHS for bacteria suffering from UV. We think the CAHS protein is a very potential protective agent, so we can use the CAHS protein to store plasmid and bacteria. We can even design a kit for the bacteria storage with CAHS protein.</p>
                                </div>
+
                <p>After being irradiated by UV for 1min, the B+ group was still alive. Therefore, we think the CAHS protein can provide protection for bacteria against UV and can protect the nucleic acid in the bacteria. The water bear can survive from UV, and the bacteria can also survive from UV, so it is certain the CAHS protein works.</p>
                                <div id="collapse114-2-5" class="panel-collapse collapse" role="tabpanel">
+
                <p>As for the colony recovery rate, the CAHS also showed great effect. The B+ group colony recovery rate was highest, which reached about 40%. While those of the B- group and B0 group were no more than 2%. After being irradiated by UV for 1min, the B+ group was still the highest in the three group (UB_B0, UV_B+ and UV_B-).</p>
                                    <div class="panel-body">
+
                <p class="F2">
                                        <p>Laws regulate the human world steadily and sustainably, without which we may fall into disorder. The medical reform policies, together with the reasonable superintendence will promote the rapid progress of POCT(point-of-care testing) in America <sup>[3]</sup>.
+
                    <img src="https://static.igem.org/mediawiki/2018/b/bb/T--XMU-China--results3-12.png">
                                        </p>
+
                    <p class="Figure_word">
                                        <p class="F3"><img src="https://static.igem.org/mediawiki/2018/d/d7/T--XMU-China--hp-111i.png"></p>
+
                        <strong>Figure 12.</strong> The colony recovery rate. (B0 is E.coli-BL21 without BBa_K2623014, B+ is E.coli-BL21 with BBa_K2623014 and IPTG, B- is E.coli-BL21 with BBa_K2623014, UV means the desiccant bacterial under UV for 1min.)
                                            <p>America now is encountered with the payment pressures imposed by enormous medical insurance fees resulted from the aged tendency of population and the changes in the spectrum of diseases. According to the forecast by CBO, the expense of health products will reach up to 4,600 billion in 2020, accounting for 20% of the GDP. Besides, it was shown in the OECD report that in 2011, American people’s average expenditure on health care was up to 8233 dollars, twice the expenditure of comparatively developed European countries like French, Switzerland and England. In March, 2010, American president Barack Obama carried out the “Affordable Care Act”, aiming at improving the quality of American health insurance service, and decreasing the cost of health care service. The “ACA Act” established the balance sharing plan, which encouraged doctors and hospitals to meet the patients’ medical needs by an integral medical service system through encouraging accountable care organizations. Under that balance sharing plan, suppliers and organizers of the service who meet the standard set by US HHS can serve those who benefits from the medical insurance plan through co-organizing and coordinating. ACO could help reduce the cost and increase the efficiency, and distribute part of the surplus among members. Under the design of the ACO system, the new service supplying mode integrate hospitals, general practitioners, medical specialists and other specialists to answer for the medical quality and medical cost together [4]</p>
+
                </p>
                                            <p class="F3"><img src="https://static.igem.org/mediawiki/2018/7/78/T--XMU-China--hp-1222i.png"></p>
+
                <p>Here are the pictures of the culture plate. We used the disposable plastic petri dishes, and appended the sealing film on the aperture. When we started, we used the glass petri dishes, but the effect was not obvious at all. All the petri dishes had chloramphenicol, and the B0 group bacteria had transformed BBa_S0100.</p>
                                                <p>In America, POCT is supervised by FDA, and is co-organized by certification authority, POCT committee, and POCT coordinators. It exists as one of the branches of IVD. Therefore, it is also supervised under the policies of medical apparatus and instruments. At the same time, IVD products are also supervised under CLIA 88 enacted in 1992, which divided IVD into three registering levels (low, medium and high) basing on the complexity of experiments. Before obtaining the right of market entrance, producers have to make appliances according to CLIA categorizing system. After that, CMS, DCLD and CDC will check the products and authorize corresponding CLIA certifications. When it comes to POCT products specially, they will have to firstly recognized by JCAHO and CAP, and finally authorize and certificate by JCAHO, CMS and CAP [5].</p>
+
                <p class="F25">
                                                <p class="F3"><img src="https://static.igem.org/mediawiki/2018/9/92/T--XMU-China--hp-333.png"></p>
+
                    <img src="https://static.igem.org/mediawiki/2018/6/61/T--XMU-China--results3-13.png">
                                                    <p>In terms of the usage of POCT products, owing to the fact that there is not much barrier, the superintendence is therefore the key to optimizing POCT and enlarging its range of application. POCT committees have been set in every organization, city and state in America so as to implement quality-superintendence over its usage and guarantee the accuracy of the testing results [6].</p>
+
                    <p class="Figure_word">
                                                    <p class="F3"><img src="https://static.igem.org/mediawiki/2018/8/81/T--XMU-China--hp-4444.png"></p>
+
                        <strong>Figure 13.</strong> the plate of colony for counting. (B0 is E.coli-BL21 without BBa_K2623014, B+ is E.coli-BL21 with BBa_K2623014 and IPTG, B- is E.coli-BL21 with BBa_K2623014, UV means the desiccant bacterial under UV for 1min. And the 104 & 105 means Dilution ratio)
                                                        <h1>References</h1>
+
                </p>
                                                        <p>[1] Yanling Song, Zhi Zhu, Yuan An, Weiting Zhang, Huimin Zhang, Dan Liu, Chundong Yu, Wei Duan, Chaoyong James Yang, Selection of DNA Aptamers against Epithelial Cell Adhesion Molecule for Cancer Cell Imaging and Circulating Tumor Cell Capture, Anal Chem, 2013, 85, 4141-4149. <br>
+
                <h1>Conclusion</h1>
                                                            [2] Liang Cui, Yuan Zou, Ninghang Lin, Zhi Zhu, Gareth Jenkins, Chaoyong James Yang, Mass Amplifying Probe for Sensitive Fluorescence Anisotropy Detection of Small Molecules in Complex Biological Samples, Anal Chem, 2012, 84, 5535−5541. <br>
+
                <p>Our experiment shows the great function of CAHS protein in improving the desiccation tolerance and UV tolerance. We think that the CAHS protein is a very potential protective agent for bacteria storage. Except expressing the CAHS protein with plasmid, we can also knock the CAHS protein gene into the genome of bacteria through homologous recombination. And we believe that a new way for storing the bacteria is available.</p>
                                                            [3] https://www.house.gov/ <br>
+
                                                            [4] https://www.aha.org/ <br>
+
                                                            [5] http://www.gf.com.cn/ <br>
+
                                                            [6] https://www.fda.gov/</p>
+
                                    </div>
+
                                </div>
+
                            </div>
+
                        </div>
+
                    </div>
+
                </div>
+
 
             </section>
 
             </section>
 
         </div>
 
         </div>
 +
        <!-- <script type="text/javascript" src="js/right.js"></script> -->
 
         <script src="https://2018.igem.org/Team:XMU-China/js/right?action=raw&ctype=text/javascript"></script>
 
         <script src="https://2018.igem.org/Team:XMU-China/js/right?action=raw&ctype=text/javascript"></script>
 
         <button class="material-scrolltop" type="button"></button>
 
         <button class="material-scrolltop" type="button"></button>
Line 662: Line 609:
 
         window.jQuery || document.write('<script src="js/jquery-1.11.0.min.js"><\/script>')
 
         window.jQuery || document.write('<script src="js/jquery-1.11.0.min.js"><\/script>')
 
         </script>
 
         </script>
 +
        <!-- <script src="js/material-scrolltop.js"></script> -->
 
         <script src="https://2018.igem.org/Team:XMU-China/js/material-scrolltop?action=raw&ctype=text/javascript"></script>
 
         <script src="https://2018.igem.org/Team:XMU-China/js/material-scrolltop?action=raw&ctype=text/javascript"></script>
 
         <div class="footer">
 
         <div class="footer">
Line 688: Line 636:
 
                 </ul>
 
                 </ul>
 
             </div>
 
             </div>
            <div class="bottom"></div>
 
 
         </div>
 
         </div>
 +
        <div class="bottom"></div>
 
</body>
 
</body>
  
 
</html>
 
</html>

Revision as of 02:06, 18 October 2018

Team:XMU-China/Results - 2018.igem.org

Results
The result of ABCD system

What work we've done:

Verified the concept of our design for three modules respectively.

Verified the activity of EpCAM.

Verified the successful combination between SYL3C aptamer and EpCAM.

Verified that SYL3C aptamer could combine with 10nt complementary chain successfully.

Verified the feasibility of “competition method” successfully.

Verified that As Cas12a could be activated.

Verified the trans-cleavage activity.

Transferred molecular signal to fluorescence signal with DNase Alert.

Verified the transfer from protein signal to the fluorescent one successfully

The work hasn’t finished yet:

Quantitative analysis of the effect of "competition method" and "As Cas12a system" respectively

Verified the detection limit of "competition method", "As Cas12a system", and then our whole system

Other designs to transfer signals for reporting devices

Activity of EpCAM (Flow cytometry)

We got EpCAM directly from ACROBiosystems. In order to prove that the protein was still bio-active, we chose antibody of EpCAM with fluorescence and flow cytometry to measure it. Furnished by the research group laboratory, the fluorescence antibody was proved effective through previous experiments.

We bought EpCAM with His-tag tag. It’s widely known that His-tag could chelate with nickel ions, so we incubated EpCAM protein with nickel beads to bind them together. Adding the antibody and then incubating, we measured them with flow cytometry. At the same time, we started two other control group experiments, with the result shown below. Get more information of our experiment, click here.

Name Events % Parent % Grandparent % Total PE-A Mean PE-A Geo Mean
ni-beads:P1 5,087 94.52 *** 94.52 108 82
ni-beads+antiepcam:P1 5,208 91.45 *** 91.45 2,880 2,626
EpCAM+Anti-EpCAM:P1 4,238 93.53 *** 93.53 14,816 14,211

Figure 1: the result of detecting the binding of EpCAM with fluorescent antibody, with flow cytometry.
a) Black line: pure nickel beads;
b) Blue line: nickel beads + fluorescent antibody (measure the non-specific adsorption between beads and antibody);
c) Red line: nickel beads - EpCAM complex + fluorescence antibody.

From the graph and data above, we could find out that the non-specific adsorption between nickel beads and fluorescent antibody does exist, but in the presence of EpCAM, the fluorescence intensity increased seven times compared with the original one, so we could prove that our bio-active EpCAM protein successfully combined with fluorescent antibody.

Combination between SYL3C and EpCAM (fluorescence polarization)

Although EpCAM and aptamer SYL3C are directly quoted in the literature [1], we believed that we still needed to verify this step and that we could ensure the validity of our material.

We struggled with this step for a long period, and we suspected that our failure was caused by impure materials. We used 30KDa ultrafiltration tube - through which unbound fluorescent aptamers could pass, but the aptamer combined with protein could not. We also used flow cytometry to directly detect whether there were binding fluorescent aptamers on EpCAM, without satisfying results in the end.

Fortunately, we successfully validated this step with the fluorescence polarization method after replacing materials, with the proposal from Prof. Zhi Zhu. We incubated two groups, namely pure fluorescence aptamers as well as fluorescent aptamers with EpCAM without light at the same time, then adding binding buffer to the total volume of 200μL. After incubation, we added 3mL binding buffer for fluorescence polarization. Get more information of our experiment, click here.

Figure 2.1: polarizing fluorescence intensity of fluorescence aptamer.

Figure 2.2: polarizing fluorescence intensity of fluorescent aptamers with EpCAM, after incubation.

According to the principle of fluorescence polarization, the FP value would depend directly on the effective molecular size of the fluorescent group at fixed temperature and viscosity of solution. For small molecules (fluorescent aptamers) with fast Brownian rotation in solution, the FP value was lower; while for larger molecules (fluorescent aptamers combined with EpCAM), the FP value was higher. [2]

The FP value could be calculated by the following formula:

Below are four maximum fluorescence values for calculating FP values:

Later, we could calculate whether the FP value of fluorescent aptamers increased with EpCAM incubation according to the principle. If the FP value increased, it showed that fluorescent aptamers did bind to EpCAM. We calculated the difference herein:

With an increase of 0.142, the difference was rather obvious, which demonstrated that the fluorescent aptamer did combine with EpCAM.

Combination between SYL3C and the “complementary chain” (DNA agarose gel electrophoresis)

We've been struggling for some time due to one problem about how to prove that our aptamers and the complementary chains were combined, which would be paramount for our following experiments.

We tried SYBR Green I, a fluorescent dye that could be embedded in a double helix of DNA and thus significantly enhance fluorescence intensity, since it could distinguish ssDNA from dsDNA obviously. However, there's no significant difference according to our results. We speculated that the sequence might be not long enough, coupled with the formation of secondary structure of aptamers, leading to no difference in fluorescence intensity.

Finally, we exploited the conventional gel electrophoresis method to prove this block, and then gel electrophoresis was performed immediately after grouping and denaturing annealing. Because the sequence was too short, we did not have the appropriate DNA marker to use. Get more information of our experiment, click here.

Figure 3: gel image of aptamer combined with complementary chain.
a) W1: aptamer;
b) W2: 24nt complementary chain with a 9nt complementary part;
c) W3: 24nt complementary chain with a 10nt complementary part;
d) W4: Aptamer+ 24nt complementary chain with a 9nt complementary part;
e) W5: Aptamer+ 24nt complementary chain with a 10nt complementary part;

We could find that there were three distinct bands between the aptamer + complementary chains with a 10nt complementary part (W5), while 9nT did not. The lane 1 and 2 acted as markers, so we could clearly identify the positions of the aptamers and complementary chains in the three bands. The last band, obviously, was the result of an increase in molecular weight, which meant that the aptamer and the complementary chain combined together successfully.

Therefore, we have proved that the aptamer could combine with its complementary chain successfully.

The competition (Spectrofluorometer)

We used the competition method to transfer molecular signal, because we considered that the competition method was best operated automatically later, so that users did not need to have a deep understanding toward technical basis. Therefore, it's quite important for us to verify that EpCAM could compete successfully, from a theoretical prospective to support our hardware and the activation of Cas12a as well.

Below are the exact procedures of our experimental group. First, we successfully hatched the streptavidin beads, biotin-modified aptamers and fluorescent complementary chains to form the complexes, then fixed the beads with magnets and discarded the supernatant, which would still contain fluorescent complementary chains that did not form complexes. After that, we incubated the complex with EpCAM to achieve the process of competition.

Additionally, considering the non-specific adsorption, we set up several control groups, and the variables amongst them were replaced by buffer. After competition, we fixed the magnetic beads with magnet, then extracted the supernatant and added 3mL incubation buffer in tandem. Below is the plot about the fluorescence intensity detected in different groups. Get more information of our experiment, click here.

Figure 4: fluorescence intensity images of competition results
a) Black line: incubation buffer;
b) Red line: magnetic beads - aptamer + incubation buffer;
c) Blue line: magnetic beads - aptamer - complementary chain complex + incubation buffer;
d) Green line: magnetic beads - aptamer - complementary chain complex + EpCAM + incubate buffer.

Comparing the four groups, we can conclude that the non-specific adsorption of complementary chains on the magnetic beads does exist, and the magnetic bead-aptamer complex, like the buffer solution, had almost no fluorescence. Significantly, the fluorescence intensity of the competition group with EpCAM was about 2.5 times larger than that of the non-specific adsorption group, which demonstrated that the fluorescence complementary chain of the competition group with EpCAM was successful, and so was our competition method.

Trans-cleavage activity of Cas12a (Microplate Reader)

It's reported that cas12a could be activated by ssDNA and has trans-cleavage activity this year, so we hope to use this function in our system to amplify the signal. [3]

We operated the experiment according to the instructions from IDT. We incubated the cas12a protein with crRNA to form a complex and then added our ssDNA to be recognized. Then, we used the commercial DNase Alert Kit to explore its trans-cleavage activity. We drawed the fluorescence curve with time using a microplate reader, and measured the fluorescence from 30 minutes to 110 minutes

In order to control variables, we also set up a negative (DNase Alert) and a positive (DNase I + DNase Alert) control group. Get more information of our experiment, click here.

Figure 5: ffluorescence time curve image of activation effect of cas12a
a) Black line: negative group, DNase Alert only;
b) Red line: positive group, DNase I + DNase Alert;
c) Blue line: experimental group, activated cas12a+DNase Alert;

We fitted three sets of data points with Gaussian fitting curve in Figure 5. From the fitting results, we could see that the negative group and the positive group were declining, while the cas12a proteome increased at first and then decreased. This is in line with our expectations, and the reason for the decline was, we suspected, the quenching caused by continuous measurements and the weakening of the fluorescence itself as the experiment proceeds. However, it's enough to prove that cas12a could meet the expected result of amplifying signals.

Signal transformation by DNase Alert (Spectrofluorometer)

Although we have used DNase alert to detect Cas12a, as the last of the three modules we designed, we needed to prove that DNase alert was indeed cut and would emit fluorescence to our expectations, so that it could be used to transfer our signals.

Here, we chose DNase I to verify directly. In the presence or absence of DNase I, we measured fluorescence intensity in the DNase alert tube. Considering the experiences we got previously that long-term measurement in the microplate reader would lead to reduction in fluorescence intensity, resulting in experimental error, we chose spectrophotometer instead.

We set up the experimental group (with DNase I) and the control group (without DNase I), with the time gradient of 3, 15, 30 minutes. All groups started at the same time. We didn’t operate continuous measurement, to avoid excitation that may cause partial fluorescence quenching. After incubation, 3mL TE buffer was added, and then detect the fluorescence. Get more information of our experiment, click here.

Figure 6: fluorescence intensity curve in 3rd minutes, with or without DNase I

Figure 7: fluorescence intensity curve in 15th minutes, with or without DNase I

Figure 8: fluorescence intensity curve in 30th minutes, with or without DNase I

From the Figure 6-8, we could find that cutting efficiency of DNase I was very high, almost all of the DNase Alert substrate has been cut in 3 minutes, fluorescence in 15 and 30 minutes and 3 minutes almost keep the same level. As we expected, DNase alert could indeed be cleaved and then re-released as a fluorescent group. In other words, DNase alert could transfer the molecular signal to the fluorescent signal actually.

Integrated experiment

After making each part work effectively, we accomplished the integrated experiment finally, transferring the protein signal to fluorescent one.

Similarly, following procedures mentioned in the "competition method" part, we successfully hatched the streptavidin beads, biotin-modified aptamers and fluorescent complementary chains to form the complexes, then fixed the beads with magnets and discarded the supernatant, which would still contain fluorescent complementary chains that did not form complexes. After that, we incubated the complex with EpCAM to achieve the process of competition. After competition, we fixed the magnetic beads with magnet, adding the supernatant extracted into Cas12a-crRNA complex incubated previously to activate Cas12a protein. Finally, we added it into DNase Alert, supplementing 3mL TE buffer after 30 minutes to measure the fluorescent intensity. Below is the corresponding plot we've obtained, indicating that we made the integrated experiment successfully.

Figure 9: Integrated experiment

References

[1] Yanling Song, Zhi Zhu, Yuan An, Weiting Zhang, Huimin Zhang, Dan Liu, Chundong Yu, Wei Duan, Chaoyong James Yang, Selection of DNA Aptamers against Epithelial Cell Adhesion Molecule for Cancer Cell Imaging and Circulating Tumor Cell Capture, Anal Chem, 2013, 85, 4141-4149.
[2] DS Smith, SA Eremin, Fluorescence polarization immunoassays and related methods for simple, high-throughput screening of small molecules, Analytical and bioanalytical chemistry, 2008, 391 (5) :1499.
[3] Chen JS, Ma E, Harrington LB, Da Costa M, Tian X, Palefsky JM, Doudna JA, CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity, Science, 2018, 360 (6387) : seaar6245

The result of OMVs

The growth curve of IPTG-induced and Arabinose-induced E. coli BL21

To ensure when we should add the inducer, we measured the growth curve of BBa_K2623026 (IPTG-induced) and BBa_K2623027 (Arabinose-induced). According to figure 1a, we found that after incubation for 5 h, the OD600 of BBa_K2623026 (IPTG-induced) reached to about 0.6, which is suitable for adding IPTG to a final concentration at 0.5 mM. Figure 1b shows that after incubation for 5 h, the OD600 of BBa_K2623027 (Arabinose-induced) reached to about 0.6, which is suitable for adding Arabinose to a 0.2% final concentration.

Figure 1. Growth curve of (a) IPTG-induced and (b) Arabinose-induced E. coli BL21.

OmpA-ST could be transported to OMVs

OmpA-SpyTag (OmpA-ST) is transported to bacterial outer membrane and therefore OMVs. However, E. coli could produce natural OmpA and then transport it to its outer membrane and OMVs as well. It’s necessary to know how much OmpA-ST is transported to OMVs or what the ratio of the OMVs-ST is in total OMVs. To evaluate the efficiency of its transport to outer membrane and OMVs, we fused wtGFP and our OmpA-ST (BBa_K2623022 and BBa_K2623024) together in order to construct OmpA-ST-GFP (BBa_K2623021 and BBa_K2623023) (Figure 2).

Figure 2. The spectrogram of wtGFP [1].

We cultured bacteria transfected with these four parts respectively in 10 mL OMVs-free LB broth culture and extracted the OMVs according to our protocols, in which two forms of non-GFP OMVs were set as negative controls. Transmission electron microscopy (TEM) pictures identified what we extracted were exactly OMVs with membrane structure and 100-nm diameter (Figure 3).

Figure 3. TEM figures identify our OMVs.

Building upon Yan’s lab-built high-sensitivity flow cytometer [2] [3], we successfully detected the OMVs labelled with GFP and evaluated the efficiency of its transport to OMVs (Figure 4). Herein, we'd like to extend our heartfelt thanks toward Yan's lab due to the very kind and selfless help during the experiment.

Figure 4. HSFCM analysis of OmpA-ST-GFP inside OMVs.

Figure 4 are bivariate dot-plots of GFP green fluorescence versus side scattering (SSC) for our OMVs isolates. E. coli transfected with BBa_K2623021 (Figure 4a) could secret more OMVs labeled with GFP than E. coli transfected with BBa_K2623022 (Figure 4b). Similarly, E. coli transfected with BBa_K2623023 (Figure 4c) would secret more OMVs labeled with GFP than E. coli transfected with BBa_K2623024 (Figure 4d). Moreover, we could see E. coli transfected with BBa_K2623021 (Figure 4a) would transport OmpA-ST to OMVs more efficiently than E. coli transfected with BBa_K2623023 (Figure 4c). The remarkable difference of GFP-OMVs ratio between these two parts might account for the different inserted site of ST. SpyTag (ST) in BBa_K2623021 (Figure 4a) is inserted to N-termini of OmpA, while ST in BBa_K2623023 (Figure 4c) is inserted to C-termini of OmpA. Our HSFCM data shows that BBa_K2623021 is more efficient to transport ST-OmpA-GFP to OMVs and might be a good candidate for the following study.

References

[1] https://www.semrock.com/
[2] Zhu S, Ma L, Wang S, et al. Light-Scattering Detection below the Level of Single Fluorescent Molecules for High-Resolution Characterization of Functional Nanoparticles. Acs Nano, 2014, 8(10):10998-11006.
[3] Tian Y, Ma L, Gong M, et al. Protein Profiling and Sizing of Extracellular Vesicles from Colorectal Cancer Patients via Flow Cytometry[J]. Acs Nano, 2018, 12(1).

Demonstrate the OmpA-ST inside E. coli BL21 and OMVs

As our HSFCM data show, OmpA-ST-GFP (BBa_K2623021 and BBa_K2623023) transported to OMVs could be detected. In our total circuit, we would use non-GFP part (BBa_K2623022 and BBa_K2623024) to establish SpyTag/SpyCatcher (ST/SC) conjugation. For this purpose, we'd like to demonstrate the OmpA-ST (BBa_K2623022 and BBa_K2623024) inside both E. coli BL21 and OMVs, as well as SDS-PAGE used (Figure 5).

Figure 5. Lane 1: E. coli BL21 transfected with BBa_K2623022.
Lane 2: OMVs secreted by E. coli BL21 transfected with BBa_K2623022.
Lane 3: E. coli BL21 transfected with BBa_K2623024.
Lane 4: OMVs secreted by E. coli BL21 transfected with BBa_K2623024.

As our SDS-PAGE figure shows, ideal band at about 50 kDa are shown in E. coli BL21 transfected with BBa_K2623022 and BBa_K2623024, respectively. However, we could see neither bands nor traces in lane 2 and lane 4 loading with OMVs samples. We suppose that our sample loadings are not enough for the LOD (limit of detection) of SDS-PAGE followed by Coomassie blue staining. Because of limited time, we couldn’t repeat this experiment. Whatever, our HSFCM data have shown that OmpA-ST could be encapsulated into OMVs.

Demonstrate the SC-L7Ae inside E. coli BL21

Similarly, in our total circuit, we used non-RFP part (BBa_K2623026) to fulfill L7Ae-C/Dbox linkage. It's demonstrated that the SpyCatcher (SC)-L7Ae could be expressed inside E. coli BL21 firstly. Under the induction of IPTG at 0.5 mM, we could detect the expression of SC-L7Ae (Figure 6).

Figure 6. SDS-PAGE figure of the SC-L7Ae.
Lane 1: induced-BL21.
Lane 2: uninduced-BL21. The red arrow points to the band of the SC-L7Ae.

Though no IPTG was added into E. coli BL21 as negative control (lane 2), we could still see our band at about 70.4 kDa indicated for SC-L7Ae. However, SDS-PAGE is not an ideal approach for identify our targeted protein. In our future plans, we would use anti-SC mAb to immunoblot our SC-LA7e. (See our future plans).

Demonstrate the ST/SC conjugation inside OMVs

Though we have revealed the OmpA-ST inside OMVs, we are inclined to figure out the ST/SC bioconjugation inside OMVs. Hence, we fused mRFP1 to SC-L7Ae (BBa_K2623026) to build SC-L7Ae-RFP (BBa_K2623025) (Figure 7). We linked our two non-GFP OmpA-ST parts (BBa_K2623022 and BBa_K2623024) with BBa_K2623025 and BBa_K2623026 to form four new parts:

1) BBa_K2623022 & BBa_K2623025: BBa_K2623028 (RFP form)
2) BBa_K2623022 & BBa_K2623026: BBa_K2623029
3) BBa_K2623024 & BBa_K2623025: BBa_K2623030 (RFP form)
4) BBa_K2623024 & BBa_K2623026: BBa_K2623031

Under the induction of IPTG, L7Ae could be expressed with SpyCatcher and RFP modification and then be encapsulated into OMVs through ST/SC conjugation. OMVs labeled with RFP will be detected through HSFCM.

Figure 7. a) Genetic circuit of SC-L7Ae-RFP [1].
b) The spectrogram of mRFP1.

Figure 8. HSFCM analysis of ST/SC bioconjugation inside OMVs.

Figure 8 contains bivariate dot-plots of RFP red fluorescence versus side scattering (SSC) for our OMVs isolates. E. coli BL21 transfected with BBa_K2623028, BBa_K2623029, BBa_K2623030, BBa_K2623031 were incubated with OMVs-free LB culture for about 5 hours to get a 0.6-0.8 OD600 respectively, in which BBa_K2623029 and BBa_K2623031 were set as negative controls. Then IPTG was added to a final concentration at 0.5 mM and nurture the bacteria overnight. OMVs were isolated according to our protocols and then analyzed by HSFCM. It’s interesting to note that E. coli transfected with BBa_K2623030 (Figure 3c) could secret more RFP-OMVs than BBa_K2623028 (Figure 3a), indicating that ST/SC conjugation inside OMVs is more efficient with ST at the C-termini of OmpA. This result is inconsistent with the result shown in Figure 4, in which ST at the N-termini of OmpA (BBa_K2623028) has a higher efficiency to be encapsulated inside OMVs. We propose that GFP inserted to OmpA might interfere the transport of OmpA-ST (BBa_K2623021 and BBa_K2623023) to OMVs.

References:

[1] https://www.semrock.com/

Demonstrate the L7Ae-C/Dbox conjugation inside OMVs

Our OMVs module is designed for siRNA delivery and then for cancer treatment. To demonstrate the conjugation of the L7Ae-C/Dbox inside OMVs, we linked ST/SC part with the box part (BBa_K2623027, see Figure 9) to form our total circuit (BBa_K2623032).

Figure 9. Genetic circuit of the Box part (BBa_K2623027).

The box part can code siRNA target for Kras in human pancreatic ductal adenocarcinoma (PDAC) with a C/Dbox RNA structure to bind with L7Ae.

Under the induction of arabinose at a 0.2% final concentration, we isolated the OMVs according to our protocols and then stained the OMVs isolates with SYTOTM RNASelectTM at 10 M (Figure 10). The stained isolates were analyzed by HSFCM (Figure 11).

Figure 10. a) Schematic illustration of our total circuit.
b) The spectrogram of SYTOTM RNASelectTM [1].

Figure 11. HSFCM analysis of OMVs stained with SYTOTM RNASelectTM..

Figure 11 are bivariate dot-plots of green fluorescence versus side scattering (SSC) for our OMVs isolates. E. coli BL21 transfected with BBa_K2623029 and BBa_K2623032 respectively were cultured in 100 mL OMVs-free LB culture for about 5 hours to get a OD600 at 0.6-0.8, in which BBa_K2623029 was set as negative control. Then Arabinose was added to a final concentration at 0.2% and after incubation for another 2 hours, IPTG was added to a final concentration at 0.5 mM and then nurtured the bacteria overnight. OMVs were isolated according to our protocols and stained with SYTOTM RNASelectTM. The stain OMVs were analyzed by HSFCM. As we expected, OMVs isolated from BBa_K2623032 could secret more OMVs containing with RNA stained positively by SYTOTM RNASelectTM (Figure 11b) than BBa_K2623029, indicating that our L7Ae and C/Dbox could fulfill their function. It’s a pity that we didn’t have cell culture experiment to test our siOMVs to silence Kras in human pancreatic ductal adenocarcinoma (PDAC). In our future plans, we’ll finish our cell experiment and demonstrate the function of our siOMVs.

References

[1] https://www.semrock.com/

Future Plan

It is not practical to transfer our ideas to a fully-completed project or even a portable device just after an enriched summer. We should learn more for the sake of improving our project, making it suitable for feasible usage. Therefore, we list our future plans to develop our projects.

Design-1. Though we have characterized OmpA-ST through SDS-PAGE, in many cases SDS-PAGE is not an optimal method to characterize specific protein in complex samples, like bacterial lysates. For further characterizing our OmpA-ST, we would be inclined to find monoclonal antibody (mAb) specific for SpyTag and Western Blot analysis alike. Exploiting with anti-SpyTag mAb, we supposed that the band at about 50 kDa would be stained positively.

Design-2. Similar to Design-1, we would also use monoclonal antibody (mAb) specific for L7Ae and SC to validate our L7Ae-SC.

Design-3. For our siRNA-C/Dbox, due to poor experimental instrument, we could only characterize the promotion of RNA level inside our engineering bacteria. The problem is that we could not ensure the presence of our siRNA target for KrasG12D. To characterize this part better, we'd like to use qPCR, FISH (fluorescence in situ hybridization) or low-throughput miRNA target identification method[1] to demonstrate our siRNA could target KrasG12D. Through the incubation of siOMVs (OMVs containing siRNA) and human pancreatic ductal adenocarcinoma (PDAC) cell line PANC-1, the silence effect of the siOMVs could be told.

Design-4. As mentioned above, our chassis is bacterium. Some researchers have demonstrated not only bacteria but also their OMVs could be pathogenetic. Though some governments have approved the usage of OMVs vaccines, the side effects of the OMVs are still ambiguous. Extracellular vesicles (EVs), originated from eukaryocytes, which are often referred to exosomes and mircovesicles, are better choices for nucleic acid delivery for its biocompatibility and homology. We could conjugate L7Ae to the C-terminus of tetraspanin CD63 and insert a C/Dbox into the 3′-untranslated region (3′-UTR) of the gene coding for siRNA[2].

References

[1] Michael J V, Jgt W, Mao G F, et al. Platelet microparticles infiltrating solid tumors transfer miRNAs that suppress tumor growth[J]. Blood, 2017, 130(5): blood-2016-11-751099.
[2] Kojima R, Bojar D, Rizzi G, et al. Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for Parkinson’s disease treatment[J]. Nature Communications, 2018, 9(1):1305.

The result of Supporting

Verify the expression of SAHS protein

Firstly, we used the BBa_E1010 (mRFP) as our report gene to make sure the circuit for expressing the SAHS protein was constructed precisely. But we did not observe the distinct color on the plate as it was so weak unless the E.coli was cultured in a tube and centrifuged. So we had a new test by using the BBa_K592009(blue chromo protein)as our report gene and got a distinct color on the plate.

Figure 1. These are the pictures our fluorescently characterized plate and bacterial pellets. The report gene on the left is BBa_K592009, and the one on the right is E1010. Some colonies on the left are blue, which are the DH5α that we successfully transferred to the designed genetic loop. The leftmost EP tube in the right photo is the control, and the other two EP tubes contain DH5α which we had successfully transferred to the designed genetic loop.

And then, we transformed the plasmid to the E.coli-BL21, which is always used to express proteins with high efficiency to verify the SAHS protein was produced successfully with a small scale. Besides, whether the SAHS protein with a signal peptide could be secreted was determined by SDS-PAGE.

Figure 2. The marker is on the lest, followed by our control group (the BL21 with the empty plasmid), and the third well is the concentrated supernatant.

As shown in the image above, we also explored the appropriate temperature for SAHS protein expression. As we expected, protein expression was be more efficient at 30 °C. However, we did not find the SAHS protein band in the supernatant even when it was concentrated by ultrafiltration. So we speculated that cell wall obstructed the secretion of protein on the basis of 2016 Peking University’s working. See more information on the page.

Therefore, we have to design a new protein purification program. To get enough protein produces for the following experiment, the gene was cloned into the vector pET-28a with high expression lever combined with E.coli-BL21. Besides, Two HIS-TAGs on the end of N-and C-terminal was produced and allow SAHS protein to bind with Nickel column (like Ni-NTA) for purification. Meanwhile, we purified the sample with heat water bath considering the characterization of heat stability by following the reference.

Figure 3. The picture on the left is a series of temperature gradient processed protein samples. The number represents the temperature (°C). And the picture on the right is the gel map of our final purified high purity SAHS protein.

So, we designed a set of temperature gradients from 70°C to 90°C, to explore the appropriate condition. What’s more, we chose the 85℃ for 15mins finally for large scale purification. But given that there were many other protein bands, we combined heating with Nickel column for producing high quality protein. Finally, we tested two patterns, heating-Ni-NTA and Ni-NTA-heating, and found that the later one is better.

After that, we obtained a protein sample with high concentration and purity by using this protein purification method(Figure 3).

Verify the role of SAHS protein in preserving biological activity

In order to verify the preservation effect of SAHS protein, we used the lyophilization method. First, we tested the concentration of purified SAHS protein, which ranged from 0.3 g/L to 0.6 g/L. Then, we concentrated the purified protein to control the protein concentration to about 1 g/L.

We selected Taq enzyme as the protein preserved in our experiment, using SAHS protein as protective agent, and set a series of concentration gradients: 1g/L, 0.5g/L, 0.1g/L, 0.01g/L and 0g/L, then stored with lyophilization. In order to verify the preservation effect of SAHS protein, we resuscited the lyophilized sample and performed PCR experiments to verify the activity of Taq enzyme. The activity of Taq enzyme can be reflected by the product of PCR.

Figure 4. PCR results of Taq enzymes preserved at different SAHS protein concentrations.

We selected different PCR systems for verification. We found that some short fragments were easy to succeed, but there was no obvious gradient. However, when we replaced them with some other fragments that are difficult to succeed or very long, there would show a very obvious gradient. We think it must be that a shorter fragments were too easy to succeed, and made the base too large. The two fragments above are pET-28a, which had a relatively obvious gradient and also had a good repeatability.

Figure 5. The result of the comparison of PBS and ultra-pure water. Blank is the group that the Taq enzyme has not been lyophilized and without SAHS protein.

In addition, we also made a comparison between PBS and ultra-pure water. We found that regardless of the presence of TDP, the lyophilized system added with PBS could not make the correct band. On the contrary, there was only one large band which was much larger than 8000bp. We think it may be a PCR mismatch. Considering that PBS contained a large amount of salt, it was likely that these salt ions affected the binding of Taq enzyme to Mg2+.

Figure 6. The ruselt of the success rate of PCR with Taq enzymes preserved at different SAHS protein concentrations.

Then, we tried some shorter fragments for PCR, and interfered with the PCR system by reducing time extension and reducing the concentration of the template in order to explore the success rate of PCR. As the figure showed, when the concentration of SAHS protein was 0.5g/L, the success rate of PCR was the highest. We suspected that excessive concentration of SAHS protein might affect the normal function of the Taq enzyme and might affect the binding of the enzyme to the substrate. This reminded us of the results of TUDelft in 2017. They also got the result of that 0.5g/L was better than 1g/L in some cases. Eventually, they took a concentration of 1g/L to preserve Cas13a. They discovered that while CAHS 94205 preserved Cas13a’s RNase-like activity after drying, CAHS 94205 could not preserve its specificity. This is exactly the same as ours when the concentration is 1g/L. Therefore, we believe that it is possible that they just did not find the most suitable storage concentration, and if the concentration is properly reduced, the results may be much better.

Conclusion

According to the experimental results of lyophilization above, we can clearly see the preservation effect of SAHS protein on protein activity. Secondly, when the concentration is too high, SAHS protein may affect the normal function of protein. Therefore, it is necessary to find the most appropriate concentration. The optimal concentration may vary slightly among different proteins, but the preservation of biological activity by SAHS proteins is undoubtable. We believe that SAHS protein is a promising bioactive protective agent for different preservative substances, as long as the appropriate preservation system is set up.

Verify the expression of CAHS protein

Figure 7. The circuit of BBa_K2623014

In the circuit, the Lac I was expressed constantly, and Lac O, lac repressor was bound to Lac O. Following the CAHS gene was our reporter gene mRFP (J04650). When we added IPTG in the bacterial solution, the IPTG bound to repressor and inactivated it. So the CAHS gene and mRFP would start to express.

Figure 8. the E.coli-DH5а with BBa_K2623014 and IPTG turns red.(D+ is E.coli-DH5а with BBa_K2623014 and IPTG, D- is E.coli-DH5а with BBa_K2623014 without IPTG, D0 is E.coli-DH5а without BBa_K2623014)

We found that the red fluorescent protein expressed very slowly. After we added IPTG in the 4mL bacterial solution, we put the bacterial solution in 25° shaker culture. After 12 hours, we saw the centrifugal precipitation color showed red.

We also did experiment with E.coli-BL21, but the bacteria didn’t turn red.

We cultured the E.coli-BL21 which contained the plasmid of CAHS protein (BBa_K2623014) in the fluid medium. When the value of OD600 reached about 0.6, we took 4ml bacteria solution in the glass test tubes and added 4μL IPTG in the tubes. And then put them in 25° shaker culture for 5hs. Then, we took 1mL bacterial liquid to centrifugalize. We picked the precipitation and added 100μL DDW and 20μL SDS loading buffer. After that, we heated and boiled it for 15 minutes. And then, it was separated by SDS-PAGE and stained with Coomassie brilliant blue for 40 minutes. Ultimately, we decolorized it and observed the results.

We find the CAHS is surely expressed in the E.coli-BL21 after adding IPTG. Here is the result.

Figure 9. the CAHS protein express in SDS-PAGE. (1, 2, 3 is all with BBa_K2623014. 1 is BL21 with IPTG and pre-heat, 2 is BL21 with IPTG, 3 is BL21 without IPTG, 4 is BL21 without the BBa_K2623014.)

The picture of SDS-PAGE shows the CAHS protein is surely expressed in B+ group (the E.coli-BL21 with BBa_K2623014 with IPTG). And CAHS protein isn’t expressed in the B- group (the E.coli-BL21 with BBa_K2623014 without IPTG) and B0 group (the E.coli-BL21 without BBa_K2623014).

We also did experiments with E.coli-DH5а, but the SDS-PAGE showed there was no CAHS protein. Because the E.coli-BL21 is a kind of strain which can knock out proteases while the E.coli-DH5а not. We guess the CAHS protein in E.coli-DH5а is degraded. So we chose the BL21 to verify the function of CAHS.

Verify the role of CAHS protein in preserving biological activity

The SDS-PAGE showed the CAHS protein was really expressed in BL21. We cultured the E.coli-BL21 bacteria which contained the plasmid BBa_K2623014. We picked the E.coli-BL21 bacterial liquid for freeze-drying. First of all, we picked 1mL bacterial liquid to centrifugalize, added 100μL protective agent (LB+5% Sucrose), and put them in -20°refrigerator for 2h. And then, we put them in -80° for one thorough night, and then freeze-dried them (Advantage ES-53).

After lyophilization, we added 500μL PBS in each centrifuge tube, and put them in 37° shaker culture for 15mins. We also added 500μL DDW in each centrifuge tube. And then, we took 100μL the dilute bacteria liquid, added in 900μL DDW, repeated the step, and carried out gradient dilution to 104, 105, 106. Then, we picked 200μL dilute bacteria liquid, and coated the plate with chloramphenicol.

Figure 10. gradient dilution.

The results showed that CAHS protein could improve the preservation effect of freeze-drying bacteria significantly!

The B+ group’s CFU is 100 times higher than the B0 group, 30 times better than the B- group. So we think the CAHS is leaking expression in B- group, which has some of the protection for the bacteria in freeze-drying.

After being irradiated by UV for 1min, the B0 group was nearly fully dead, and the CFU of B- group had been decrease to a very low level, while the B+ group was higher. So we think the CAHS is can provide some of certain protection against UV.

Figure 11. The CFU of BL21. (B0 is E.coli-BL21 without BBa_K2623014, B+ is E.coli-BL21 with BBa_K2623014 and IPTG, B- is E.coli-BL21 with BBa_K2623014, UV means the desiccant bacterial under UV for 1min.)

This result shows that the CAHS can provide production for bacteria in freeze-drying. And the CAHS can also provide CAHS for bacteria suffering from UV. We think the CAHS protein is a very potential protective agent, so we can use the CAHS protein to store plasmid and bacteria. We can even design a kit for the bacteria storage with CAHS protein.

After being irradiated by UV for 1min, the B+ group was still alive. Therefore, we think the CAHS protein can provide protection for bacteria against UV and can protect the nucleic acid in the bacteria. The water bear can survive from UV, and the bacteria can also survive from UV, so it is certain the CAHS protein works.

As for the colony recovery rate, the CAHS also showed great effect. The B+ group colony recovery rate was highest, which reached about 40%. While those of the B- group and B0 group were no more than 2%. After being irradiated by UV for 1min, the B+ group was still the highest in the three group (UB_B0, UV_B+ and UV_B-).

Figure 12. The colony recovery rate. (B0 is E.coli-BL21 without BBa_K2623014, B+ is E.coli-BL21 with BBa_K2623014 and IPTG, B- is E.coli-BL21 with BBa_K2623014, UV means the desiccant bacterial under UV for 1min.)

Here are the pictures of the culture plate. We used the disposable plastic petri dishes, and appended the sealing film on the aperture. When we started, we used the glass petri dishes, but the effect was not obvious at all. All the petri dishes had chloramphenicol, and the B0 group bacteria had transformed BBa_S0100.

Figure 13. the plate of colony for counting. (B0 is E.coli-BL21 without BBa_K2623014, B+ is E.coli-BL21 with BBa_K2623014 and IPTG, B- is E.coli-BL21 with BBa_K2623014, UV means the desiccant bacterial under UV for 1min. And the 104 & 105 means Dilution ratio)

Conclusion

Our experiment shows the great function of CAHS protein in improving the desiccation tolerance and UV tolerance. We think that the CAHS protein is a very potential protective agent for bacteria storage. Except expressing the CAHS protein with plasmid, we can also knock the CAHS protein gene into the genome of bacteria through homologous recombination. And we believe that a new way for storing the bacteria is available.